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ABSTRACT
The decline of proteostasis is a hallmark of aging that is, in part, affected by the dysregulation of
the heat shock response (HSR), a highly conserved cellular response to proteotoxic stress in the
cell. The heat shock transcription factor HSF-1 is well-studied as a key regulator of proteostasis,
but mechanisms that could be used to modulate HSF-1 function to enhance proteostasis during
aging are largely unknown. In this study, we examined lysine acetyltransferase regulation of the
HSR and HSF-1 in C. elegans. We performed an RNA interference screen of lysine
acetyltransferases and examined mRNA expression of the heat-shock inducible gene hsp-16.2, a
widely used marker for HSR activation. From this screen, we identified one acetyltransferase,
CBP-1, the C. elegans homolog of mammalian CREB-binding protein CBP/p300, as a negative
regulator of the HSR. We found that while knockdown of CBP-1 decreases the overall lifespan
of the worm, it also enhances heat shock protein production upon heat shock and increases
thermotolerance of the worm in an HSF-1 dependent manner. Similarly, we examined a hallmark
of HSF-1 activation, the formation of nuclear stress bodies (nSBs). In analyzing the recovery rate
of nSBs, we found that knockdown of CBP-1 enhanced the recovery and resolution of nSBs after
stress. Collectively, our studies demonstrate a role of CBP-1 as a negative regulator of HSF-1
activity and its physiological effects at the organismal level upon stress.
Defects in proteostasis that occur with aging are also central to many human diseases, including
Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease. These neurodegenerative
diseases (NDDs) are proteotoxic diseases hallmarked by increased protein misfolding and
aggregation. Many components of the heat shock response are downregulated in NDD and aging,
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including HSF1. The regulation of HSF-1 in neurodegenerative diseases has yet to be fully
elucidated. Thus, we examined regulation of HSF1 and its target genes in NDD models in C.
elegans. We found that hsf-1 expression is decreased in an Alzheimer’s disease model expressing
human amyloid-β1-42 (Aβ). In contrast, we found that the presence of Aβ increased the
expression of heat shock inducible HSF-1 target genes hsp-16.2 and hsp-70. To further examine
the relationship between HSF-1 and Aβ, we utilized an endogenous HSF-1::GFP worm strain
previously made in the lab that we then crossed with the Aβ model of Alzheimer’s disease to
visualize tissue-specific HSF-1 expression in the disease state and with age. We visualized HSF1::GFP foci in multiple tissue types in the Aβ background. Collectively, these findings begin
uncovering the regulation of HSF-1 and the heat shock response in neurodegenerative disease in
C. elegans.
Lastly, the mechanism of HSF1 degradation in general, and in neurodegenerative disease in
particular, is not thoroughly characterized. Recent studies have identified two E3 ubiquitin
ligases, FBXW7 and NEDD4, that target HSF1 for degradation in Huntington’s and Parkinson’s
disease, respectively. Our goal is to further elucidate the mechanism of HSF1 degradation in
neurodegenerative disease using C. elegans models. We have found that knockdown of the C.
elegans homologs for FBXW7 and NEDD4, sel-10 and Y92H12A.2, does not alter HSP reporter,
hsp-16.2p::GFP and hsp-70p::GFP, activity in the wildtype background. However, we also
examined E3 ligase knockdown in a Huntington’s disease model that expresses polyglutamine
expansions with age. In this neurodegenerative disease background, we found that sel-10 and
Y92H12A.2 RNAi increased motility and thermotolerance. Thus, both E3 ligases only regulate
the HSR in the presence of polyglutamine expansions. These studies provide more knowledge on
the regulation of HSF-1 in neurodegenerative disease, specifically Huntington’s disease, and a
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potential mechanism for the decrease in HSR activity in the presence of proteotoxic aggregate
formation.
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CHAPTER ONE: INTRODUCTION
The Proteostasis Network and the Heat Shock Response
Protein homeostasis, or proteostasis, is the proper balance of protein folding, trafficking, and
clearance in the cell (Labbadia & Morimoto, 2015). The proteostasis network is a multicompartmental system that encompasses the entire protein life cycle, from protein synthesis and
folding to protein disaggregation and degradation. The regulation of proteostasis is critical for
cell survival and function (Labbadia & Morimoto, 2015). There are three highly linked branches
of this network that maintain the proteome: protein synthesis and folding, protein maintenance,
and protein degradation. This network is comprised of ~2,000 proteins in human cells that
control and regulate these branches to ensure proper cell survival (Labbadia & Morimoto, 2015).
Protein synthesis and folding
The human proteome is highly complex, with each cell and tissue type having a unique and
distinct composition of proteins (Kulak, Geyer, & Mann, 2017). Each protein also ranges
significantly in their abundance, and this can also vary between cell types (Geiger, Wehner,
Schaab, Cox, & Mann, 2012). Once a protein is synthesized, it must be folded into its native state
in order to function properly. The native or folded state of the protein is generally
thermodynamically favorable. Proteins are folded with the help of molecular chaperones, or
proteins that interacts and stabilizes or aids in the folding of another protein without being a part
of its final form (Y. E. Kim, Hipp, Bracher, Hayer-Hartl, & Hartl, 2013). Many molecular
chaperones are also known as heat shock proteins, as they were discovered to be synthesized
1

upon stress and also aid in the refolding of proteins that are misfolded or aggregated after stress
(Y. E. Kim et al., 2013). Maintaining proper folding of proteins is critical to their function and
overall cell survival.
Protein degradation
In conjunction with protein synthesis and maintenance, regulation of protein degradation is
essential for controlling functional proteostasis (Labbadia & Morimoto, 2015). Proteins are
degraded by two pathways: the ubiquitin-proteasome system (UPS) and the autophagy-lysosome
pathway (ALP) (Dikic, 2017). In general, the UPS is primarily used to degrade short-lived,
misfolded, or damaged proteins, whereas the ALP is used to remove larger components like
protein aggregates or damaged organelles (Dikic, 2017). Proteins needing to be sent for
degradation to the proteasome are tagged with a residue of the ubiquitin protein that the
proteasome can then recognize and begin a series of enzymatic reactions to degrade the targeted
protein (Wang & Le, 2019). The process of ubiquitination is comprised of three enzymes: the E1
enzyme that activates ubiquitin, the E2 molecule that binds to the ubiquitin, and the E3 ligase
that transfers the ubiquitin from the E2 molecule to the targeted protein. There are hundreds of
E3 ligases that bind to specific substrates for ubiquitin transfer (Wang & Le, 2019). On the other
hand, ALP utilizes bi-layered membrane vesicles called autophagosomes that engulf damaged
proteins or organelles. Autophagosomes can then directly fuse to the lysosome for degradation
where the degraded contents can be recycled back into the cell. The regulatory mechanism and
selectivity for autophagy is highly complicated and specific (Wang & Le, 2019). Overall,
disposal of damaged proteins and organelles through both systems is necessary for proper
proteostasis in the cell.
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Protein maintenance and the heat shock response
One of the main functions of the proteostasis network is to prevent the formation of misfolded
proteins or toxic aggregates that form from stress or disease. To do this, the cell has multiple
stress response pathways to ensure proper protein maintenance, including the heat shock
response (HSR) and the unfolded protein response (UPR). The UPR is a signal transduction
pathway that senses and responds to abnormal protein misfolding or unfolding in the
endoplasmic reticulum (ER) (Hetz, Zhang, & Kaufman, 2020). The UPR utilizes three main
signaling pathways: via PERK to attenuate protein synthesis in cell (Kaufman, 2002); via IRE1α
to reduce protein abundance in the ER (Hollien & Weissman, 2006); and via ATF6 to promote
transcription of ER chaperones and enzymes to promote protein folding and degradation (J. Wu
et al., 2007).
Similarly, the unfolded protein response in the cytosol, also known as the heat shock response
(HSR), responds to proteotoxic stress in the cytosol. The HSR is a highly conserved response to
stressors such as heat shock, heavy metals, and oxidative stress (Labbadia & Morimoto, 2015).
Genes encoding for molecular chaperones are induced by heat shock transcription factor 1
(HSF1) and aid in the re-folding or degradation of damaged proteins. Upon stress, HSF1
trimerizes and induces transcription of molecular chaperones, including heat shock proteins
(HSP) HSP70, HSP90, and HSP60 (Westerheide, Anckar, Stevens, Sistonen, & Morimoto,
2009). These heat shock proteins guide protein folding and degradation to equilibrate the
proteostasis of the cytosol. Upon attenuation, HSF1 is degraded by the UPS (Kourtis, Moubarak,
et al., 2015). The transcriptional activity of HSF1 is stress inducible and highly regulated
(Westerheide, Raynes, Powell, Xue, & Uversky, 2012).
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History of the Heat Shock Response
The HSR was initially discovered in the 1960s by Ferruccio Ritossa, who was studying DNA in
Drosophila melanogaster (Ritossa, 1996). While studying fruit fly chromosomes, a colleague
mistakenly increased the temperature of the incubator the fruit flies were kept in and Ritossa
observed a novel puffing pattern in the chromosomes. The puffing of the chromosomes indicated
that there was an increase in transcriptional activity with increased temperatures (Ritossa, 1996).
Then in the 1970s, with the radiolabeling of mRNA and proteins, global changes in transcription
and translation were observed to occur after heat shock (Lewis, Helmsing, & Ashburner, 1975;
Spradling, Pardue, & Penman, 1977). This included the upregulation of certain genes and their
protein products which were subsequently called heat shock proteins. The Morimoto laboratory
found a particular HSP with a molecular weight of 70 kDa, HSP70, to be highly induced upon
heat shock (Mosser, Theodorakis, & Morimoto, 1988). While examining the promoter region of
hsp70, the group discovered a series of three inverted repeats of the sequence nGAAn, which
they coined as heat shock elements (HSEs) (B. J. Wu, Kingston, & Morimoto, 1986). This
ultimately led to the discovery of the transcription factor that binds to these regions, heat shock
factor 1 (Goldenberg et al., 1988; Parker & Topol, 1984; Wiederrecht, Shuey, Kibbe, & Parker,
1987). From here, work on the HSR and HSF1 has grown to better understand its mechanism,
regulation, and implications in many diseases.
HSF1 Structure and Domains
The structure of HSF1 is defined by its functional domains that allow for regulation of the
protein-quality control machinery to regulate gene expression. The winged helix-turn-helix DNA
binding domain (DBD) is at the amino-terminal end of HSF1 and allows for binding at HSEs
along the DNA (Vuister et al., 1994). Because HSF1 trimerizes upon activation, a trimerization
4

domain is located adjacent to the DBD. This domain contains hydrophobic leucine-zipper-like
heptad repeats (HR-A/B) that allow for oligomerization (Sorger & Nelson, 1989). In order to
activate target gene expression, HSF1 also contains a transactivation domain (TAD) at the
carboxyl-terminal that binds to auxiliary factors for activation (Sullivan, Weirich, Guyon, Sif, &
Kingston, 2001). A regulatory domain (RD) is also present to negatively regulate the TAD (Shi,
Kroeger, & Morimoto, 1995).
HSF1 Activation and Attenuation Cycle
HSF1 activation
HSF1 is found in both the nucleus and cytoplasm and rests in the inactive state, which is mostly
as a monomer (Anckar & Sistonen, 2011). Monomeric HSF1 binds to a variety of chaperones
including heat shock proteins, HSP70 and HSP90. Upon heat stress, HSF1 is activated by
trimerizing and becoming DNA-binding-competent (Joutsen & Sistonen, 2019). Active HSF1
accumulates in the nucleus due to its nuclear localization sequence, and trimeric HSF1 can then
bind to HSEs found in the promoter regions of its target genes (Amin, Ananthan, & Voellmy,
1988; Mercier, Winegarden, & Westwood, 1999). HSF1 activation is also highly dependent on
post-translational modifications (PTMs) or other protein-protein interactions (Joutsen &
Sistonen, 2019). It is still unclear the exact mechanism of HSF1 activation, but there are several
proposed mechanisms that could be dependent on stress-type. It is suggested that HSF1 binding
to HSPs keeps HSF1 in its inactive state. Upon heat stress, the HSPs get titrated away from
HSF1 to bind to the increased accumulation of misfolded proteins in the cell. This allows for
HSF1 to trimerize and activate (Bharadwaj, Ali, & Ovsenek, 1999; Sivery, Courtade, &
Thommen, 2016; Zou, Guo, Guettouche, Smith, & Voellmy, 1998). Another proposed
mechanism is that HSF1 is a thermosensor and activates by sensing changes in temperature
5

(Hentze, Le Breton, Wiesner, Kempf, & Mayer, 2016). Overall, HSF1 activation is highly
regulated and allows for specific induction of the HSR in the cell.
HSF1 localization and nuclear stress bodies
Upon heat stress and as HSF1 activates, scientists have observed distinct HSF1 foci formation in
the nucleus called nuclear stress bodies (nSBs) (Jolly, Usson, & Morimoto, 1999). nSBs are a
hallmark of HSF1 activation (Biamonti & Vourc'h, 2010; Deonarine, Walker, & Westerheide,
2021; Jolly et al., 2004; Jolly et al., 1999; Morton & Lamitina, 2013). In mammalian cells, the
resolution of nSBs correlates with HSF1 activity, transcription of hsp target genes, and cell
survival at the single cell level (Gaglia et al., 2020). A recent mammalian study discovered the
existence of both HSF1 nSBs at non-hsp gene loci and smaller HSF1 condensates at
transcriptionally active hsp gene loci upon heat shock (H. Zhang et al., 2022). In this study,
HSF1 in the smaller condensates was found to colocalize with transcription apparatus factors,
including RNA Pol II, BRD4, MED1, and CYCT1 (H. Zhang et al., 2022). The precise function
of nSBs and HSF1’s localization to nSBs after activation has yet to be fully elucidated.
HSF1 attenuation
Once the HSR has been activated and the HSP target proteins have been translated to aid in the
refolding of misfolded proteins, the HSR requires inactivation. Through the modification of
multiple inhibitory PTMs and other proteins including HSPs, HSF1 gets inactivated, dissociates
from the DNA, and gets targeted to the proteasome for degradation. With an increase in free
HSPs in the cell, these HSPs can subsequently re-associate with HSF1 and inhibit its activation
in a feedback loop (Sivery et al., 2016). Also, many PTMs aid in the removal of HSF1 from the
DNA and prevent transcription from occurring (Raychaudhuri et al., 2014; Westerheide et al.,
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2009). Degradation of HSF1 is also a pathway of HSF1 attenuation that has not fully been
elucidated. Studies in neurodegenerative disease have examined the aberrant mechanisms of
HSF1 degradation, but it is still unclear where HSF1 degradation occurs and the extent of which
HSF1 is recycled during attenuation (Gomez-Pastor et al., 2017; E. Kim et al., 2016). Ultimately,
inactive HSF1 remains in the cytosol and nucleus until needed for further activation.
Post-translational Modifications of HSF1
Like many transcription factors, HSF1 is highly regulated via post-translational modifications
(PTMs). These modifications have been shown to contribute to every step in the activation of
HSF1 from oligomerization to DNA binding to attenuation as well as its deactivation (Joutsen &
Sistonen, 2019). Theses PTMs are added to all HSF1 domains for their regulation, and HSF1 is
subjected to many PTMs including phosphorylation, acetylation, ubiquitination, and
sumoylation, many with a complex set of roles in activation or attenuation of HSF1 (Joutsen &
Sistonen, 2019).
Acetylation of HSF1 via Lysine Acetyltransferases
Acetylation refers to the reversible addition of an acetyl group to the side of a lysine residue of a
protein that causes neutralization of the positive charge of lysine (Narita, Weinert, & Choudhary,
2019). This modification can have a variety of effects on the protein’s stability, conformation, or
function. Proteins and histones get acetylated by lysine acetyltransferases (KATs) and conversely
removed by lysine deacetylases (Narita et al., 2019). Acetylation has been shown to have a
variety of functions in regulating HSF1, with 11 lysine residues of HSF1 that have been shown
to be acetylated (Raychaudhuri et al., 2014; Westerheide et al., 2009). Under non-stressed
conditions, HSF1 levels are tightly controlled by the acetylation of specific lysine residues (K208
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and K298) (Raychaudhuri et al., 2014). These acetylation sites mediate HSF1 stabilization by
preventing its degradation by the proteasome. As well, these acetylation events were found to be
acetylated by the histone acetyltransferase EP300 (Raychaudhuri et al., 2014). This histone
acetyltransferase was also found to acetylate K80 of HSF1 which prevents HSF1 binding to the
DNA, aiding in the attenuation of the HSR (Westerheide et al., 2009).
The effects of acetylation at K80 and K118 can be reversed by the deacetylase, sirtuin (SIRT1),
which has been shown to deacetylate HSF1 at these sites (Westerheide et al., 2009). SIRT1 was
found to prolong the HSR by preventing HSF1 attenuation. When SIRT1 levels are depleted, the
ability of HSF1 to bind to target gene promoter regions is greatly reduced (Westerheide et al.,
2009). Similarly, the age-related decline in HSF1 levels is thought to partially be affected by a
decrease in SIRT1 levels with age, leading to an increase in K80 acetylation-dependent
proteasomal degradation in neuronal cells (Zelin & Freeman, 2015).
Phosphorylation of HSF1 via Protein Kinases
Phosphorylation of proteins occurs by protein kinases that catalyze the transfer of an additional
phosphate group to their substrates (Cheng, Qi, Paudel, & Zhu, 2011). There are approximately
23 known sites of phosphorylation of HSF1, most of which are found in the regulatory domain
(Guettouche, Boellmann, Lane, & Voellmy, 2005). Upon heat shock, hyperphosphorylation of
HSF1 occurs with HSF1 activation and DNA binding (Cotto, Kline, & Morimoto, 1996).
However, HSF1 can still be transcriptionally active even in the absence of any phosphorylation
event. It is thought that HSF1 phosphorylation is more of a fine-tuning mechanism for its activity
(Budzynski, Puustinen, Joutsen, & Sistonen, 2015). There are a variety of protein kinases that
have been found to directly interact with HSF1 and can phosphorylate HSF1 at similar residues
but in distinct contexts. The serine residues S303 and S307 can be phosphorylated by many
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protein kinases, including GSK3β, casein kinase 2 (CK2), MEK1 and ERK1 (Chu, Zhong,
Soncin, Stevenson, & Calderwood, 1998; Gomez-Pastor et al., 2017). These phosphorylation
events lead to the ubiquitination of HSF1 and to its degradation via the proteasome. In
Huntington’s disease, phosphorylated HSF1 at these serine residues is a substrate for FBXW7, a
component of the E3 ubiquitin ligase system (Gomez-Pastor et al., 2017).
Sumoylation of HSF1
Sumoylation is another type of PTM that involves the addition of a small ubiquitin-like modifier
to specific lysine residues (Yang et al., 2017). HSF1 is primarily sumoylated on K298 but can
also be sumoylated on the K126 residue (Hong et al., 2001). K298 sumolyation is a part of the
phosphorylation-dependent sumoylation motif (PDSM), where the phosphorylation of S303 is
required for SUMO-1 to be added at K298. Sumoylation at this site is not required for HSF1
activity but functions as a negative regulator of its transactivation activity (Hong et al., 2001).
Additional sites of HSF1 sumoylation have recently been identified by a screen, but their
functions have not been examined (Hendriks & Dingemans, 2017).
Ubiquitination of HSF1
The abundance and activity of HSF1 is also partially regulated by the ubiquitin-proteasome
system to degrade HSF1 in the cell (Raychaudhuri et al., 2014). Ubiquitination of HSF1 on its
lysine residues lead to its degradation by the proteasome. Two ubiquitin ligases, FBXW7 and
NEDD4, have been shown to interact and ubiquitinate HSF1 (Gomez-Pastor et al., 2017; E. Kim
et al., 2016). The sites of HSF1 ubiquitination are unknown, but the interaction between FBXW7
and HSF1 is dependent on the phosphorylation of S303 and S307 as mentioned previously
(Gomez-Pastor et al., 2017). It was found that HSF1 degradation is an important step in its
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attenuation, where previously HSF1 was just thought to revert back to its monomeric state
(Kourtis, Strikoudis, & Aifantis, 2015).
HSR Regulation in Aging and Disease
In neurodegenerative disease
Defects in proteostasis and the HSR that occur with aging are central to many human diseases,
including Alzheimer’s disease, Huntington’s disease, and Parkinson’s disease (Neef, Jaeger, &
Thiele, 2011). These neurodegenerative diseases (NDDs) are proteotoxic diseases hallmarked by
increased protein misfolding and aggregation (Muchowski & Wacker, 2005). Huntington’s
disease is hallmarked by the abnormal polyglutamine expansion in the Huntingtin protein in the
N-terminal domain. These polyglutamine expansions can aggregate together causing large
inclusion bodies of aggregating Huntingtin protein (Havel, Li, & Li, 2009). Alzheimer’s disease
results from the aggregation of the toxic protein amyloid-beta. The accumulation and
aggregation of this protein causes neuronal loss in the brain leading to dementia or loss of
cognition (Mavroudis et al., 2010). Parkinson’s disease is hallmarked by the aggregation of the
protein alpha-synuclein that form Lewy bodies and leads to loss of dopaminergic neurons in the
brain (E. Kim et al., 2016).
This protein toxicity of these neurodegenerative diseases leads to neuronal dysfunction and
subsequent neuronal death, causing various symptoms for patients from dementia to tremors.
Protein toxicity disrupts the proteostasis in the cell that is needed for its proper function
(Labbadia & Morimoto, 2015). Current drug treatments of these neurodegenerative diseases
combat the symptoms associated with these diseases but not the underlying proteotoxicity
causing these symptoms (Gomez-Pastor, Burchfiel, & Thiele, 2018). Therefore, novel
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therapeutic drugs are currently needed to treat these diseases and the underlying proteostasis
dysfunction caused by the proteotoxicity of the protein aggregates. Studies in the heat shock
response have demonstrated therapeutic potential in enhancing the protein folding capacity of
cells (Neef et al., 2011).
It has been widely documented that HSF-1 and heat shock protein activity is impaired in aging
and neurodegenerative diseases (Anckar & Sistonen, 2011). Downregulation of the heat shock
response in these protein misfolding diseases contributes to the protein aggregation and overall
neuronal dysfunction and death (Gomez-Pastor et al., 2017). Many studies have found that
upregulating HSF1 or HSP activity has beneficial effects on the proteotoxicity of the diseases
(Neef et al., 2011). Previous studies have shown that HSF1 levels and HSP levels are depleted in
Alzheimer’s, Huntington’s, and Parkinson’s disease patient brains (Gomez-Pastor et al., 2017;
Jiang et al., 2013; E. Kim et al., 2016). In Huntington’s and Parkinson’s disease, the depletion of
HSF1 is due to its degradation, but it is unclear if the same is true in Alzheimer’s disease.
Abnormal degradation of HSF1 in Huntington’s was found to be mediated by proteasomal
degradation via the E3 ligase FBXW7 (Gomez-Pastor et al., 2017). Similarly, HSF1
phosphorylation at S303 and S307 was found to mediate this degradation by FBXW7. HSF1
phosphorylation was found to be modified by casein kinase 2. Both CK2 and FBXW7 are
upregulated in Huntington’s disease (Gomez-Pastor et al., 2017).
HSF1 degradation in Parkinson’s disease was found to involve the E3 ligase NEDD4, which is
upregulated in the diseased patients (E. Kim et al., 2016). It is unclear if this HSF1 degradation
also requires HSF1 phosphorylation, although it has been reported that CK2 expression is
increased in Parkinson’s disease as well (Lee et al., 2004). For Alzheimer’s disease, it is
unknown if HSF1 is degraded or if HSF1 phosphorylation mediates its degradation, but similar
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to the other disease models, HSF1 protein levels are decreased and CK2 levels are increased in
Alzheimer’s patients (Jiang et al., 2013; Rosenberger et al., 2016). It is also unclear if there are
other E3 ligases that also aid in the degradation in these diseases. Understanding how HSF1 is
being regulated in neurodegenerative disease could provide insight into novel therapeutics to
reduce or prevent the protein aggregation associated with neurodegenerative disease.
In cancer
In contrast to decreased levels of HSF1 found in neurodegenerative disease, HSF1 levels are
increased in many cancers (Mendillo et al., 2012; Meng, Gabai, & Sherman, 2010). Similarly,
increased chaperone expression has been observed in a variety of different cancers, aiding in the
increase of protein synthesis that occurs in these cancers (Whitesell & Lindquist, 2005).
Malignant cells are prone to proteotoxic damage and stress and in general require a higher
amount of HSPs to function in their unstable environment (Whitesell & Lindquist, 2005). HSF1
and its target proteins have been well studied in cancer. Overall, a decrease of HSF1 protects
against tumorigenesis and malignancy (Dai, Dai, & Cao, 2012). Thus, identifying specific HSF1
therapeutic targets has large appeal.
C. elegans as a Model Organism
Experimental advantages of C. elegans
C. elegans is a powerful model organism to study cellular processes like the heat shock response.
Their short life cycle (3-4 days) and lifespan (2-3 weeks) allows for rapid aging studies. Their
transparent anatomy allows for in vivo visualization of fluorescently tagged proteins via
fluorescence microscopy (Nussbaum-Krammer & Morimoto, 2014). Similarly, the different
tissue types can be easily distinguished throughout the worm anatomy allowing for tissue12

specific experimentation. C. elegans was the first multicellular organism to have its genome
sequenced. The full sequenced genome and mutant worm strains are freely available in public
databases and resources. Approximately 80% of the proteins encoded in the C. elegans genome
are conserved in vertebrates as well. Gene expression can be targeted through RNA interference
(RNAi) by either feeding worms bacteria that produce double stranded RNA (dsRNA) or by
injection of dsRNA into the worm (Kamath et al., 2003).
Neurodegenerative disease models in C. elegans
Many age-related protein misfolding disorders and neurodegenerative diseases are modeled in
the worm, and a large number of these strains have fluorescently tagged protein aggregation that
allows for visualization (J. Li & Le, 2013). The fluorescently tagged proteins that are linked to
these diseases are generally aggregating proteins that can be easily visualized in the cells. Many
of these aggregating proteins cause toxicity that results in paralysis or tissue damage that can be
measured (Brignull, Morley, & Morimoto, 2007). For example, there are a wide variety of C.
elegans neurodegenerative disease models that allow for whole organism assessment of the
disease state. Many of these worm disease models mimic the production of the disease protein
aggregates throughout the worm’s life cycle (2-3 weeks) through transgenic expression (J. Li &
Le, 2013). This allows for the protein aggregates to be expressed in certain tissue types like the
muscle or neuron cells. The tissue-specificity of these models can be beneficial when examining
whole-organism effects.
Regulation of the HSR by HSF-1 in C. elegans
The heat shock response in highly conserved in C. elegans. Studies in C. elegans have shown
that HSF-1 is an essential protein that plays a major role in development and organismal
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physiology. HSF-1 is required for heat shock response activation and plays an important role in
development and aging (Hsu, Murphy, & Kenyon, 2003). Knockdown of HSF-1 results in a
stress-sensitive and rapid aging phenotype (Garigan et al., 2002). Overexpression of HSF-1
increases longevity and cytoprotection of the worm (Morley & Morimoto, 2004). Structurally,
HSF-1 is very similar to its mammalian homolog. Both contain a DNA-binding domain, an
oligomerization domain, and a transactivation domain (Hajdu-Cronin, Chen, & Sternberg, 2004).
HSF-1 in C. elegans has been shown to also require trimerization and hyperphosphorylation for
activation after heat shock (Morton & Lamitina, 2013). There have been studies identifying
regulators of the heat shock response (Guisbert, Czyz, Richter, McMullen, & Morimoto, 2013);
however, there is still much to understand about how C. elegans HSF-1 is regulated and
activated. How these regulators of the heat shock response affect the physiology of the worm at
the organismal level has yet to be elucidated.
CBP-1 Regulation in C. elegans
The activity of CREB binding protein CBP-1, the C. elegans homolog of CBP/p300, is highly
conserved and makes C. elegans a useful model organism to study the regulation of CBP-1
during stress and aging. HSF-1 has been shown to interact with CBP-1 in lifespan regulation (M.
Zhang et al., 2009); however, the mechanism by which CBP-1 regulates HSF-1 has not been
examined. CBP-1 in C. elegans functions as a chromatin remodeler and lysine acetyltransferase
that can regulate transcription (Victor et al., 2002). CBP-1 is an essential protein for embryonic
development, cell differentiation, and aging, and knockdown of cbp-1 significantly reduces
lifespan (Cai et al., 2019; Shi & Mello, 1998; Victor et al., 2002; M. Zhang et al., 2009). CBP-1
also acts in multiple stress response pathways, including the mitochondrial unfolded protein
response and the oxidative stress response (Ganner et al., 2019; T. Y. Li et al., 2021). Although
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CBP-1 interactions with HSF-1 have been described, its role, as well as the potential role of other
lysine acetyltransferases, in regulating HSF-1 and the HSR are still unknown.
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CHAPTER TWO: THE P300/CBP LYSINE ACETYLTRANSFERASE CBP-1
REGULATES THE HEAT SHOCK RESPONSE IN C. ELEGANS
Note. From “The p300/CBP lysine acetyltransferase CBP-1 regulates the heat shock response in
C. elegans,” by L.N. Barrett and S.D. Westerheide, 2022, to Frontiers in Aging, section Aging,
Metabolism and Redox Biology. Copyright 2022 by Copyright Holder. Reprinted with
permission.
Text adapted from manuscript submitted to Frontiers in Aging, section Aging, Metabolism and
Redox Biology.
Abstract
The decline of proteostasis is a hallmark of aging that is, in part, affected by the dysregulation of
the heat shock response (HSR), a highly conserved cellular response to proteotoxic stress in the
cell. The heat shock transcription factor HSF-1 is well-studied as a key regulator of proteostasis,
but mechanisms that could be used to modulate HSF-1 function to enhance proteostasis during
aging are largely unknown. In this study, we examined lysine acetyltransferase regulation of the
HSR and HSF-1 in C. elegans. We performed an RNA interference screen of lysine
acetyltransferases and examined mRNA expression of the heat-shock inducible gene hsp-16.2, a
widely used marker for HSR activation. From this screen, we identified one acetyltransferase,
CBP-1, the C. elegans homolog of mammalian CREB-binding protein CBP/p300, as a negative
regulator of the HSR. We found that while knockdown of CBP-1 decreases the overall lifespan

16

of the worm, it also enhances heat shock protein production upon heat shock and increases
thermotolerance of the worm in an HSF-1 dependent manner. Similarly, we examined a hallmark
of HSF-1 activation, the formation of nuclear stress bodies (nSBs). In analyzing the recovery rate
of nSBs, we found that knockdown of CBP-1 enhanced the recovery and resolution of nSBs after
stress. Collectively, our studies demonstrate a role of CBP-1 as a negative regulator of HSF-1
activity and its physiological effects at the organismal level upon stress.
Introduction
One of the hallmarks of aging is the dysregulation of protein homeostasis, or proteostasis, in the
cell which is critical for cell survival and function (Lopez-Otin, Blasco, Partridge, Serrano, &
Kroemer, 2013). The heat shock response (HSR) is a key player in the proteostasis network,
known to play a role in a variety of physiological processes, including development,
reproduction, aging, and age-related diseases (Joutsen & Sistonen, 2019). The HSR is a highly
conserved cellular response that maintains proteostasis in the cell through the activation of heat
shock transcription factor 1 (HSF1). HSF1 is the master regulator of the HSR and when
activated, drives the expression of heat shock proteins (HSPs) that act as molecular chaperones
to restore proteostasis after stress (Hartl, Bracher, & Hayer-Hartl, 2011). HSF1 has been
implicated in a wide array of age-related diseases, including neurodegenerative diseases,
metabolic diseases, and cancer (Gomez-Pastor et al., 2018). Understanding HSF1 regulation with
aging may be useful when developing therapeutic strategies for such diseases.
The transcriptional activity of HSF1 is stress-inducible and highly regulated (Westerheide et al.,
2012). Human HSF1 is regulated in part through post-translational modifications. These
modifications include acetylation, phosphorylation, and sumoylation, and they function in both
the activation and attenuation of HSF1 (Gomez-Pastor et al., 2018). Studies have shown multiple
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site-specific, reversible acetylation modifications on HSF1 that affect its overall protein stability
and attenuation (Raychaudhuri et al., 2014; Westerheide et al., 2009; Zelin & Freeman, 2015).
Under non-stress conditions, HSF1 levels are stabilized by the acetylation of Lys208 and Lys298
by the lysine acetyltransferase (KAT) CBP/p300 (Raychaudhuri et al., 2014). During stress,
CBP/p300 also mediates the acetylation of Lys80 of HSF1, which aids in inhibiting HSF1
binding to DNA to attenuate the HSR (Raychaudhuri et al., 2014; Westerheide et al., 2009).
There are also multiple other known sites of HSF1 acetylation where the effect of acetylation has
yet to be elucidated.
The activity of HSF-1, the C. elegans homolog of HSF1, is highly conserved and makes C.
elegans a useful model organism to study the regulation of HSF-1 during stress and aging. HSF1 has been shown to interact with CREB binding protein CBP-1, the C. elegans homolog of
CBP/p300, in lifespan regulation (M. Zhang et al., 2009); however, the mechanism by which
CBP-1 regulates HSF-1 has not been examined.
CBP-1 in C. elegans functions as a chromatin remodeler and lysine acetyltransferase that can
regulate transcription (Victor et al., 2002). CBP-1 is an essential protein for embryonic
development, cell differentiation, and aging, and knockdown of cbp-1 significantly reduces
lifespan (Cai et al., 2019; Shi & Mello, 1998; Victor et al., 2002; M. Zhang et al., 2009). CBP-1
also acts in multiple stress response pathways, including the mitochondrial unfolded protein
response and the oxidative stress response (Ganner et al., 2019; T. Y. Li et al., 2021). Although
CBP-1 interactions with HSF-1 have been described, its role, as well as the potential role of other
lysine acetyltransferases, in regulating HSF-1 and the HSR are still unknown.
In this study, we utilized C. elegans to screen for lysine acetyltransferase modulators of the HSR.
We identified a role of CBP-1 in negatively regulating the HSR in C. elegans, confirming the
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importance of this regulator in this stress response pathway. Collectively, our studies
demonstrate the ability of CBP-1 to regulate the HSR in an HSF-1 dependent-manner and
highlight its effects on stress resistance and longevity.
Methods
C. elegans strains and maintenance
The following strains were used in this study: N2 (Bristol), PS3551 - hsf-1(sy441), MH2430 –
cbp-1 (ku258), SDW015 - hsf-1(asd002(hsf-1::GFP + unc-119(+)), and SDW173. The MH2430
strain was outcrossed three times to the N2 wildtype strain to generate the SDW173 strain.
Strains were maintained at 20°C on standard NGM plates seeded with Escherichia coli OP50-1.
The synchronous population of nematodes was obtained by bleach synchronization and plated
for 19 hrs on NGM plates without food.
RNA interference (RNAi)
Synchronous L1 nematodes were grown on standard NGM plates seeded with OP50-1 bacteria
for 19 hrs to prevent potential RNAi-mediated effects on early development. Worms were
transferred onto standard NGM plates supplemented with 25 µg/ml carbenicillin and 1 mM
isopropyl‐beta‐ᴅ‐thiogalactopyranoside (IPTG) and seeded with either HT115 bacteria
containing an empty vector (EV/L4440 control) or with sequence‐verified gene‐specific RNAi
strains isolated from the Ahringer RNAi library (J. Ahringer, University of Cambridge,
Cambridge, U.K.), as previously described (Kamath et al., 2003). To induce dsRNA production,
HT115 bacteria were supplemented with 1 mM IPTG shaking at 37°C for 1 hour before seeding.
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RNA isolation and quantitative PCR
RNA was extracted with TRIzol® reagent (Ambion®, cat# 15,596–026) by standard protocol.
RNA was reverse‐transcribed using a High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, cat# 4,368,814). cDNA was diluted to 100 ng/µl to be used as a template for qRT–
PCR performed with the StepOne Plus Real‐time PCR system (Applied Biosystems, cat #
4,376,600) using iTaq™ Universal SYBR® Green Supermix (Bio‐Rad, cat# 1,725,121)
according to the manufacturer's instructions. Expression levels were analyzed via qPCR using
the ΔΔCt method. The housekeeping gene cdc-42 (R07G3.1) was used for normalization. Results
show averages of independent biological triplicates performed in technical triplicates. Statistical
analysis was performed with GraphPad (GraphPad Software, https://www.graphpad.com) using
an unpaired Student’s t-test.
Primers used: hsp16.2 (Y46H3A.3) Fwd: ACGCCAATTTGCTCCAGTCT, Rvs:
TGATGGCAAACTTTTGATCATTGT; hsp-70 (C12C8.1) Fwd:
TTCAATGGGAAGGACCTCAACT, Rvs: GGCTGCACCAAAGGCTACTG; cdc-42
(R07G3.1) Fwd: CTTCTGAGTATGTGCCGACAGTCT, Rvs: GGCTCGCCACCGATCAT;
hsp16.48 (T27E4.3) Fwd: TTGGAGAAATGCTGATCACAACTC, Rvs:
TTTTTAGTTCTCTTCCATCCAATTCA; F44E5.5 Fwd:
CTTCATGCAAAGCTATTGGTATCG, Rvs: CTTCCGAGTTGGCGAGGAT; cbp-1
(R10E11.1) Fwd: GCAGCGAAAACGGAGGAA, Rvs: GCATGGAACAAATGTGGAGTCTT;
hsf-1 (Y53C10A.12) Fwd: TGCAGCCAGGATTGTCGA, Rvs:
GGCGGCGCAAAAGTCTATT; hat-1 (M03C11.4) Fwd: ACGGACTTGCTGTCGTTAAA,
Rvs: CCGAAGATTGTCTCCTCATCTC; kat-1 (T02G5.8) Fwd:
CCACATCTGCTGCACTATCA, Rvs: GCAGTTACCGAAGAGAGAGAAG; taf-1 (W04A8.7)
20

Fwd: TACGAGGCCACAGCTTATTG, Rvs: CGCTTCTCCTCCTTATACTGTTC; mys-1
(VC5.4) Fwd: CGAGCTGCAAATGGTTCAATTA, Rvs: GTAGCTCACACGACGCTAAA;
mys-2 (K03D10.3) Fwd: GGAGCGAAAGAGCTCATGTATT; Rvs:
GCTCGACTACCACTTCGTTTAC; mec-17 (F57H12.7) Fwd:
GGTCATCAGAGCAAGGGAAA, Rvs: TTGGCCTGATGAGCTCTATTG; atat-2 (W06B11.1)
Fwd: GTTCAGCTGTGTCCAGTCAT, Rvs: TAACATATCCTGGCGCATCAA; T02G5.4 Fwd:
GCAGTTACCGAAGAGAGAGAAG, Rvs: CCACATCTGCTGCACTATCA; hsp-1
(F26D10.3) Fwd: TCAAGAGAAACACCACCATCC, Rvs: GGCACGTTCTCCTTCGTAAA;
hsp-90 (C47E8.5) Fwd: AGTACTGCGTCCAACAACTC, Rvs: TCTTCTCCTCCTCGGTTTCT
Thermotolerance analysis
Thermotolerance was tested by exposing Day 1 animals to 37°C heat shock for 3.5 hours and
then determining survival 48 hours later by assessing response to a gentle touch. For each trial,
~100 randomly selected individual animals were assessed for the fraction alive (live/total).
Thermotolerance assay data reflects three biologically independent trials. Data was plotted as the
% survival using GraphPad Prism (GraphPad Software, https://www.graphpad.com) and was
analyzed with a two-tailed t test.
Lifespan analysis
All lifespan assays were performed at 20°C with approximately 100 worms per condition in
biological triplicate. Animals were transferred to fresh plates daily for 5 days to avoid progeny
contamination. Adult worms were scored approximately every day and counted as dead when no
response was observed by poking with a platinum wire. The average survivability of three
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replicates was plotted using OASIS 2 (https://sbi.postech.ac.kr/oasis2/) (Han et al., 2016), and
statistical analysis was done by Log-rank (Mantel-Cox) Test.
Fluorescent microscopy and nuclear stress body assessment
Fluorescent images were obtained using a Keyence BZ-X fluorescent microscope. Animals were
picked free of bacteria and anesthetized with 10 mM levamisole. Nuclear stress body formation
was quantified by assessing for the presence of nuclear foci containing HSF-1::GFP in
hypodermal cells. The heat shock conditions for nuclear stress body assessment were 15 min in a
33°C water bath on plates wrapped in parafilm. After anesthetizing and placing the cover slip on
top of the worms, they were imaged within 10–15 min to avoid the formation of nuclear stress
bodies which may be due to hypoxia or other cytotoxic stress (n=~10 worms per condition).
Quantification was performed in GraphPad Prism (GraphPad Software, www.graphpad.com) and
significance was determined using 2-way ANOVA.
Thrashing assay
Thrashing/motility was tested by placing 15 Day 1 animals onto a drop of nematode growth
media (NGM) buffer on a glass slide and measuring the number of body bends/30 seconds after a
1-minute recovery period. Thrashing data reflects three biologically independent trials. Data was
plotted as boxplots using GraphPad Prism (GraphPad Software, https://www.graphpad.com) and
was analyzed with a two-tailed t test.
Statistical analyses
Statistical analyses were carried out with GraphPad Software (GraphPad Software, La Jolla, CA,
USA, https://www.graphpad.com) unless otherwise stated. All error bars are representative of
standard deviation between independent biological replicates, as indicated.
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Results
Targeted RNAi screen for lysine acetyltransferase modulators of the HSR identifies CBP-1
To identify lysine acetyltransferases that may regulate the HSR, we performed an RNA
interference (RNAi) screen by targeting ~75% of all putative lysine acetyltransferases (KATs) in
C. elegans using RNAi knockdown (Figure 2.1A). C. elegans KATs were identified by searching
the C. elegans protein database for proteins containing conserved acetyltransferase domains to
those of known human KATs (Sheikh & Akhtar, 2019). We utilized quantitative RT-PCR to
assess the heat shock inducibility of hsp-16.2 mRNA expression, a widely used marker of HSR
activity, after KAT RNAi knockdown (Golden, Plagens, Kim Guisbert, & Guisbert, 2020). We
induced RNAi 19 hours after the L1 stage until Day 1 of adulthood, when we extracted RNA
before and immediately after a 1-hour heat shock at 33⁰C to assess hsp-16.2 expression (Figure
2.1B). Our KAT and hsf-1 RNAi conditions suppress expression of their corresponding genes by
about 50% (Figure A1, Figure A2). From this screen, we found no significant changes in hsp16.2 expression in non-heat shock conditions after KAT RNAi knockdown (Figure 2.1C). After
heat shock, only RNAi for cbp-1 (R10E11.1), the homolog of human CBP/p300 CREB binding
protein, significantly altered the mRNA expression of hsp16.2 expression, resulting in an
increase in expression of approximately 2-fold (Figure 2.1C).
CBP-1 regulates the expression of multiple HSF-1 target genes in an HSF-1-dependent manner
To further examine the role of CBP-1 on the HSR, we examined how knockdown of cbp-1
affects various heat shock inducible HSF-1 target genes using qRT-PCR. The target genes tested,
including hsp-16.2, hsp.16.48, hsp-70, and F44E5.5 (an inducible hsp-70 family gene), are
highly inducible upon heat shock. We found that while cbp-1 RNAi didn’t significantly change

23

the expression of the hsp target genes tested under basal conditions (Figure A3A), cbp-1 RNAi
did significantly increase the expression of these genes after heat shock as compared to EV
control (Figure 2.2A). We also found that cbp-1 knockdown does not affect hsf-1 expression, or
vice versa (Figure A1). HSF-1 also regulates the expression of a distinct subset of developmental
genes independent of the HSR, including hsp-1 and hsp-90 (Li et al 2016). We found that cbp-1
knockdown does not affect expression of these HSF-1 target genes (Figure A3B). Thus, CBP-1 is
negatively regulating HSP but not HSF-1 expression after heat stress.
To determine whether this negative regulation of CBP-1 is mediated directly through HSF-1, we
used the PS3551 worm strain containing a non-functional HSF-1 (J. B. Zhou et al., 2018). This
mutant contains a point mutation in the HR-C domain of HSF-1 that causes the expression of a
truncated non-functional HSF-1 mutant. We then measured the expression of hsp-16.2 and hsp70 (C12C8.1) in response to cbp-1 RNAi (beginning 19 hrs after L1) before and after heat shock
in this mutant to determine dependence on HSF-1. While we found that knockdown of cbp-1
increased hsp-16.2 expression after heat shock with wildtype HSF-1 (Figure 2.1A), that increase
is abolished with a nonfunctional HSF-1. Knockdown of cbp-1 does not significantly increase
hsp-16.2 or hsp-70 (C12C8.1) expression after heat shock compared to control (Figure 2.2B).
We conclude that CBP-1 depends on HSF-1 in order to regulate hsp gene expression.
Effect of CBP-1 and HSF-1 RNAi on thermotolerance and lifespan
We next wanted to test whether CBP-1 also regulates other physiological readouts of the HSR.
To test for resistance to heat stress, we examined thermotolerance, physiological effect known to
be modulated by HSF-1. To test this, we fed the worms cbp-1, hsf-1, or control RNAi from 19
hrs after L1 until Day 1 of adulthood prior to subjecting the worms to a lethal heat shock of 37⁰C
for 3.5 hours. After a 48-hour recovery, the worms were scored alive/dead after a gentle touch.
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Compared to empty vector control RNAi-treated worms, hsf-1 RNAi-treated worms had
significantly reduced survival after heat shock (~20% decrease), as expected (Figure 2.3A).
However, knockdown of cbp-1 increased the % survival of the worms by ~40% (Figure 2.3A).
Thus, knockdown of cbp-1 increases thermotolerance.
We then performed a complimentary experiment, assessing how an increase in CBP-1 activity
would affect thermotolerance. We utilized the MH3420 strain that contains two point mutations
in cbp-1, resulting in a gain-of-function allele with increased KAT activity (Eastburn & Han,
2005). This strain was outcrossed three times with our laboratory N2 strain to create the
SDW173 strain. N2 and SDW173 worms were synchronized and grown to Day 1 of adulthood
then subjected to a lethal heat shock of 37⁰C for 3.5 hours. We found that SDW173 worms had
an ~20% decrease in percent survival as compared to N2 wildtype worms (Figure 2.3B). This
suggests that an increase in CBP-1 acetyltransferase activity decreases thermotolerance. In
summary, cbp-1 RNAi activates thermotolerance, while a cbp-1 gain-of-function mutant inhibits
thermotolerance.
Previous studies have found that cbp-1 RNAi reduces the lifespan of the worm (Cai et al., 2019;
M. Zhang et al., 2009). We wanted to test whether this effect depends on HSF-1. Worms were
fed with EV control, cbp-1, hsf-1, or cbp-1/hsf-1 double RNAi from 19 hours after L1 throughout
their lifespans. The worms were scored approximately every day starting at day 1 of adulthood
for survival, and dead worms were scored when non-responsive to poking with a platinum wire.
We found that cbp-1 RNAi decreased lifespan to a significantly lesser extent than hsf-1 RNAi
(Figure 2.3C). However, the cbp-1/hsf-1 double RNAi did not further reduce lifespan (Figure
2.3C).
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cbp-1 RNAi increases recovery rate of nuclear stress bodies (nSBs) after heat shock
Upon activation of the HSR, HSF-1 undergoes localization changes and forms nuclear stress
bodies (nSBs), a hallmark of HSF-1 activation (Deonarine et al., 2021). nSBs require HSF-1
binding and are a sign of activation of the HSR (Morton & Lamitina, 2013). After HSR
activation, nSBs form within 5 minutes of stress detection and gradually dissolve until HSF-1 is
diffuse in the nucleus (Figure 2.4A) (Deonarine et al., 2021). We examined the effect of cbp-1
RNAi on the rate of nSB recovery after stress. We used the SDW015 (HSF-1::GFP) strain to
visualize nSB formation before and after a 15-minute heat shock at 33⁰C on Day 2 of adulthood.
We utilized fluorescence microscopy to image hypodermal cells of the worm in 30-minute
increments until the majority of cells containing nSBs had diffuse HSF-1::GFP expression in the
nuclei (Figure 2.4A). After heat shock, control worms took an average of 1.7 hours to recover
and resolve their nSBs, whereas worms fed cbp-1 RNAi took an average of 1.1 hours to resolve
nSBs (Figure 2.4B). Thus, knockdown of cbp-1 significantly increased the rate of recovery of
nSBs after heat shock.
cbp-1 RNAi does not alter motility or expression kinetics of hsp-16.2 or hsp-70 after heat shock
Since CBP-1 increases the rate of recovery of nSBs, we wanted to test whether CBP-1 also
affected HSP expression kinetics after heat shock. We isolated RNA from Day 1 worms that
were fed either control or cbp-1 RNAi from 19hrs after the L1 stage. RNA was extracted from
worms before and immediately after a 15-minute heat shock at 33°C. RNA was also collected in
30-minute increments after heat shock until 2 hours of recovery. We examined how cbp-1
knockdown affects the expression of hsp-16.2 and hsp-70 expression using RT-qPCR. We found
that compared to EV control, knockdown of cbp-1 did not significantly affect hsp-16.2 or hsp-70
mRNA expression after heat shock (Figure 2.5).
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We also wanted to test whether CBP-1 affecting the worms motility. To test this, we fed the
worms cbp-1, hsf-1, or control RNAi from 19 hrs after L1 until Day 1 of adulthood. We then
placed the worms in a drop of NGM buffer and allowed them to recover for one minute before
counting the number of body bends in 30 seconds. We found that there was no significant
difference in motility between control, cbp-1 RNAi, and hsf-1 RNAi animals (Figure 2.6).
Discussion
Given the importance of post-translational modifications on HSF-1 regulation and function, we
sought to elucidate the effect of lysine acetyltransferase regulation on the HSR. Here, we
conducted a targeted RNAi screen for lysine acetyltransferase regulation of hsp-16.2 expression
levels and identified CBP-1 as a regulator of hsp expression. In addition, cbp-1 knockdown also
increased the expression of multiple other heat shock genes, increased thermotolerance, and
improved the recovery rate of nuclear stress bodies after heat stress. Overall, these studies
suggest a role for CBP-1 in negatively regulating HSF-1 activity during stress.
CBP-1 is widely known to be a transcriptional coactivator that aids in transcription (Victor et al.,
2002). We further examined various other heat-shock inducible hsp expression and found that
cbp-1 knockdown increases the expression of multiple hsps (hsp-16.2, hsp.16.48, hsp-70, and
F44E5.5) after heat shock. This type of negative transcriptional regulation is a novel role for
CBP-1 in C. elegans. However, human CBP/p300 has some characterized instances in which it
negatively regulates transcription through effects on transcription factors. For example,
acetylation of the elongation factor AFF1 by CBP/p300 inhibits transcription during genotoxic
stress (Kumari, Hassan, Lu, Roeder, & Biswas, 2019).
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CBP-1 is an essential protein that regulates multiple physiological processes including cell
differentiation, embryonic development, metabolism, lifespan, and aging (Cai et al., 2019; Shi &
Mello, 1998; Vora et al., 2013; M. Zhang et al., 2009). Specifically, CBP-1 interacts with DAF16 and HSF-1 to regulate lifespan during caloric restriction (M. Zhang et al., 2009). Similarly,
our results suggest that CBP-1 and HSF-1 work in the same pathway to regulate lifespan. While
our work suggests that CBP-1 negatively regulates the HSR, our lifespan results suggest that it
positively affects lifespan and aging. This was unexpected, as activating the HSR generally
protects from aging (Hsu et al., 2003; Morley & Morimoto, 2004). Since CBP-1 plays a positive
role in a variety of physiological pathways that control aging (Cai et al., 2019; Ganner et al.,
2019; T. Y. Li et al., 2021; M. Zhang et al., 2009; L. Zhou, He, Deng, Pang, & Tang, 2019), it
may be that the effects on these pathways are overriding the effects of CBP on HSF-1 and HSP
expression in terms of life span regulation. It will be informative in future work to determine
how the regulation of HSF-1 activity by CBP-1 can benefit aging and potentially lifespan in the
worm.
While our data indicates that CBP-1 regulates HSF-1 activity, the mechanism of this regulation
is still unknown. CBP-1 could directly acetylate HSF-1 as one potential mechanism. Mammalian
CBP/p300 acetylates HSF-1 under both stress and non-stress conditions to both stabilize HSF-1
and attenuate HSF-1 from the DNA (Raychaudhuri et al., 2014; Westerheide et al., 2009).
CBP/p300 acetylation of HSF1 could be conserved in C. elegans and function to attenuate HSF1 activity. While human CBP/p300 also acts as a scaffolding protein to recruit the transcriptional
machinery (Holmqvist & Mannervik, 2013), it is likely that worm CBP-1 regulation of the HSR
requires CBP-1 acetyltransferase activity since we found that the SDW173 mutant containing
CBP-1 with hyperactive KAT activity decreased thermotolerance. There is also the possibility of
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CBP-1 regulating HSF-1 through an indirect regulator, as CBP-1 also binds to a multitude of
other factors including the stress-responsive factors SKN-1 and DAF-16 (Ganner et al., 2019;
Nasrin et al., 2000). Future work to uncover the mechanism behind HSF-1 regulation will allow
for a more detailed analysis of the role of CBP-1 during stress and aging.
A hallmark of HSF1 activation in both mammalian cells and C. elegans is the formation and
resolution of nuclear stress bodies (nSBs) containing HSF1 (Biamonti & Vourc'h, 2010;
Deonarine et al., 2021; Jolly et al., 2004; Jolly et al., 1999; Morton & Lamitina, 2013). In
mammalian cells, the resolution of nSBs correlates with HSF1 activity, transcription
of hsp target genes, and cell survival at the single cell level (Gaglia et al., 2020). A recent
mammalian study discovered the existence of both HSF1 nSBs at non-hsp gene loci and smaller
HSF1 condensates at transcriptionally active hsp gene loci upon heat shock (H. Zhang et al.,
2022). In this study, HSF1 in the smaller condensates was found to colocalize with transcription
apparatus factors, including RNA Pol II, BRD4, MED1, and CYCT1 (H. Zhang et al., 2022). It is
thus possible that upon heat shock, HSF1 in nSBs sequesters transcription factors to halt general
transcription, while HSF1 in the smaller condensates functions to induce the transcription
of hsp target genes. HSF1 nSBs that are not able to resolve may go on to transition from liquid to
gel phase condensates, which could then permanently hinder HSF1 activity and the HSR. Our
study did not analyze small HSF-1 condensates, and it is not yet known if these are present in the
worm. However, we found that cbp-1 knockdown promotes the recovery of large HSF-1 nSBs
after heat shock. Thus, CBP-1 may facilitate the stabilization of HSF-1 nSBs, which could
promote the gel phase state upon prolonged stress, leading to ultimate HSF-1 inactivation. We
hypothesize that the removal of CBP-1 through RNAi could thus enhance the HSR. We do not
know how CBP-1 may stabilize HSF-1 nSBs. It could be through the acetylation of HSF-1 or
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another protein, through providing a scaffolding, or through an alternative mechanism. It will be
interesting to investigate these possibilities in future work.
CBP-1 also functions as a regulator of multiple other stress response pathways. Interestingly,
CBP-1 positively regulates SKN-1/Nrf activation and the oxidative stress response, where it
regulates SKN-1 activity and protein abundance (Ganner et al., 2019). CBP-1 is also an essential
regulator of the mitochondrial unfolded protein response (T. Y. Li et al., 2021). Collectively, our
studies identify a new role of CBP-1 in HSR regulation in C. elegans and its physiological
effects at the organismal level. CBP-1 negatively regulates HSP expression, nuclear stress body
recovery, and thermotolerance ability of the worm. Future work is needed to determine the
precise mechanism of action of CBP-1 in the HSR pathway and any potential acetylation
changes of HSF-1 that are induced by CBP-1.
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Figure 2.1: Targeted-RNAi screen for lysine acetyltransferase modulators of the HSR identifies
CBP-1. A) Table of all putative lysine acetyltransferases (KATs) and their human homologs. B)
Schematic of the targeted RNAi screen for lysine acetyltransferase modulators of the HSR. ~75% of
worm KATs were screened by examining endogenous hsp-16.2 gene expression, a heat-inducible heat
shock protein gene, before and after heat shock using qRT-PCR. C) N2 (wildtype) animals were fed
empty vector (EV) control or KAT RNAi from 19 hrs after L1 larval stage to Day 1 of adulthood. RNA
was extracted from Day 1 animals before and immediately after a 1-hour heat shock at 33⁰C and hsp-16.2
levels were quantified by qRT-PCR using the ΔΔCt method (n=3 biologically independent samples). The
housekeeping gene cdc-42 (R07G3.1) was used for normalization. Statistical analysis was determined by
conducting a One-Way ANOVA using GraphPad Prism (GraphPad Software, www.graphpad.com)
followed by a Tukey post hoc test comparison of all columns. *p-value < 0.05, **p-value < 0.01, ***pvalue < 0.001.
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Figure 2.2: CBP-1 regulates the expression of multiple HSF-1 target genes in an HSF-1-dependent
manner. A) RNA was extracted from N2 (wildtype) worms on Day 1 of adulthood with a 1-h heat shock
at 33°C that were fed empty vector (EV), cbp-1, or hsf-1 RNAi beginning 19 h after L1. Heat shock
inducible heat shock protein gene expression levels for hsp-16.2, hsp-16.48, F44E5.5, and hsp-70 were
quantified by qRT-PCR. B) RNA was extracted from an HSF-1 deletion worm strain (PS3551) on Day 1
of adulthood with and without a 1-h heat shock at 33°C with animals fed EV or cbp-1 RNAi. PS3551
animals were fed empty vector (EV) control or cbp-1 RNAi from 19 h after L1 larval stage to Day 1 of
adulthood. Heat shock inducible hsp-16.2 and hsp-70 levels were quantified by qRT-PCR. Statistical
analysis was determined by determined by conducting a One-Way ANOVA using GraphPad Prism
(GraphPad Software, www.graphpad.com) followed by a Tukey post hoc test comparison of all columns.
*p-value < 0.05.
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Figure 2.3: Effect of CBP-1 on thermotolerance and lifespan. A) In order to assess CBP-1 activity on
resistance to heat stress, N2 worms were given a lethal heat shock of 3.5 h at 37°C on Day 1 of adulthood
and then ∼ 100 animals were randomly scored for survival after a 48-h recovery. Percent survival was
determined for worms fed with empty vector (EV), cbp-1, and hsf-1 RNAi. Data was plotted as %
survival using GraphPad Prism (GraphPad Software, www.graphpad.com) and was analyzed with a twotailed t test. *p-value < 0.05, **p-value < 0.01, ***p-value < 0.001. B) Thermotolerance was assessed in
N2 and SDW173, a strain containing a gain-of-function allele of cbp-1 that increases acetyltransferase
activity (MH2430 strain outcrossed 3x to N2). Data was plotted as % survival using GraphPad Prism
(GraphPad Software, www.graphpad.com) and was analyzed with a two-tailed t test. *p-value < 0.05. C)
Lifespan analysis was performed in wild type N2 animals fed with EV, cbp-1 RNAi, hsf-1 RNAi, or cbp1/hsf-1 double RNAi throughout the lifespan. Worms were scored approximately every day for survival.
The average survivability of three replicates was plotted using OASIS 2 (https://sbi.postech.ac.kr/oasis2/)
(Han et al., 2016), and statistical analysis was done by Log-rank (Mantel-Cox) Test (Shown in Appendix
A1).
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Figure 2.4: cbp-1 RNAi increases recovery rate of nuclear stress bodies (nSBs) after heat shock. A)
Fluorescent images of HSF-1:GFP in the SDW015 strain were examined before heat shock and in 30-min
increments after a 15-min heat shock at 33°C for 2 h at 20°C until the majority of hypodermal cells
containing nuclear stress bodies (nSBs) had been resolved. Images represent fluorescent nSB formation in
hypodermal cells under control and cbp-1 RNAi conditions at each time point in Day 2 adult worms.
Yellow arrows indicate hypodermal cell nuclei containing nSB foci. B) The percentage of hypodermal
cells not containing nSBs were quantitated following fluorescent imaging of worms fed empty vector
(EV) control and cbp-1 RNAi (n = 10 worms). Significance was determined using 2-way ANOVA.
Column *p-value = 0.0497; row **p-value = 0.0022.
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Figure 2.5: cbp-1 RNAi does not alter expression kinetics of hsp-16.2 or hsp-70 expression after heat
shock. RNA was extracted from wildtype (N2) worms on Day 1 of adulthood that were fed empty vector
(EV), cbp-1, or hsf-1 RNAi beginning 19 hrs after L1. hsp-16.2 and hsp-70 levels were quantified by
qRT-PCR (n=3 biologically independent samples). Statistical analysis determined by determined by
conducting a One-Way ANOVA using GraphPad Prism (GraphPad Software, www.graphpad.com)
followed by a Tukey post hoc test comparison of all columns. *p-value < 0.05.
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Figure 2.6: cbp-1 RNAi does not alter motility. Motility of the N2 wildtype strain under control EV,
cbp-1, or hsf-1 RNAi was measured by placing the worms in a drop of NGM buffer and counting the
number of thrashes in 30 seconds after a 1-minute recovery period (n=~15 worms). Thrashing assay was
conducted in biological triplicate and statistics were analyzed using GraphPad Prism (GraphPad Software,
www.graphpad.com) and was analysed with a two-tailed t test. *p-value < 0.05.
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CHAPTER THREE: REGULATION OF THE HEAT SHOCK RESPONSE IN
NEURODEGENERATIVE DISEASES IN C. ELEGANS
Abstract
Defects in proteostasis that occur with aging are central to many human diseases, including
Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease. These neurodegenerative
diseases (NDDs) are proteotoxic diseases hallmarked by increased protein misfolding and
aggregation. Many components of the heat shock response, a cellular stress response that refolds
misfolded or aggregating proteins to maintain proteostasis, are downregulated in NDD and
aging, including the transcription factor Heat Shock Factor 1 (HSF1) that controls this stress
response. The regulation of HSF-1, the C. elegans homolog of HSF1, in neurodegenerative
diseases has yet to be fully elucidated. Thus, we examined regulation of HSF-1 and its target
genes in NDD models in C. elegans. We found that hsf-1 expression is decreased in an
Alzheimer’s disease model expressing human amyloid-β1-42 (Aβ). In contrast, we found that the
presence of Aβ increased the expression of heat shock inducible HSF-1 target genes hsp-16.2
and hsp-70. To further examine the relationship between HSF-1 and Aβ, we utilized an
endogenous HSF-1::GFP worm strain previously made in the lab that we then crossed with the
Aβ model of Alzheimer’s disease to visualize tissue-specific HSF-1 expression in the disease
state and with age. We visualized HSF-1::GFP foci in multiple tissue types in the Aβ
background. Collectively, these findings begin uncovering the regulation of HSF-1 and the heat
shock response in neurodegenerative disease in C. elegans.
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Introduction
Neurodegenerative diseases, such as Alzheimer’s disease, Huntington’s disease, and Parkinson’s
disease, are considered proteotoxic diseases associated with an increase in protein misfolding or
aggregation (Muchowski & Wacker, 2005). The protein toxicity of these neurodegenerative
diseases leads to neuronal dysfunction and subsequent neuronal death, causing various symptoms
for patients from dementia to tremors. Huntington’s disease is hallmarked by the abnormal
polyglutamine expansion in the Huntingtin protein in the N-terminal domain. These
polyglutamine expansions can aggregate together causing large inclusion bodies of aggregating
Huntingtin protein (Havel et al., 2009). Alzheimer’s disease results from the aggregation of the
toxic protein amyloid-β. The accumulation and aggregation of this protein causes neuronal loss
in the brain leading to dementia or loss of cognition (Mavroudis et al., 2010). Parkinson’s disease
is hallmarked by the aggregation of the protein alpha-synuclein that form Lewy bodies and leads
to loss of dopaminergic neurons in the brain (E. Kim et al., 2016).
Protein toxicity disrupts the proteostasis in the cell that is needed for its proper function
(Labbadia & Morimoto, 2015). Current drug treatments of these neurodegenerative diseases
combat the symptoms associated with these diseases but not the underlying proteotoxicity
causing these symptoms (Gomez-Pastor et al., 2018). Therefore, novel therapeutic drugs are
currently needed to treat these diseases and the underlying proteostasis dysfunction caused by the
proteotoxicity of the protein aggregates. Studies in the heat shock response have demonstrated
therapeutic potential in enhancing the protein folding capacity of cells (Neef et al., 2011).
The HSR is a key player in the proteostasis network, known to play a role in a variety of
physiological processes, including development, reproduction, aging, and age-related diseases
(Joutsen & Sistonen, 2019). The HSR is a highly conserved cellular response that maintains
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proteostasis in the cell through the activation of heat shock transcription factor 1 (HSF1). HSF1
is the master regulator of the HSR and when activated, drives the expression of heat shock
proteins (HSPs) that act as molecular chaperones to restore proteostasis after stress (Hartl et al.,
2011). The decline of HSF1 activity in aging and in neurodegenerative diseases have been well
documented (Anckar & Sistonen, 2011). For example, in patients with Alzheimer’s disease,
Purkinje cells show depleted levels of HSF1 and HSPs (Jiang et al., 2013). Similarly,
overexpression of HSF1 lowers amyloid-β levels in Purkinje cells and decreases the cognitive
impairment associated with Alzheimer’s (Pierce et al., 2013). Previous studies have also shown
that HSF1 levels and HSP levels are depleted in Huntington’s disease and Parkinson’s disease
patient brains (Gomez-Pastor et al., 2017; Jiang et al., 2013; E. Kim et al., 2016).
The activity of HSF-1, the C. elegans homolog of HSF1, is highly conserved and makes C.
elegans a useful model organism to study the regulation of HSF-1 during stress and disease. In
this study, we utilized C. elegans to examine the regulation of the HSR in neurodegenerative
disease. We discovered that hsf-1 expression is decreased in the presence of amyloid-β1-42,
especially in aging. However, conversely, we found that HSF-1 target gene expression was
increased under the same conditions. Thus, we created a worm strain to visualize HSF-1 levels in
the Alzheimer’s disease model to examine the effect of amyloid-β1-42 on HSF-1 protein levels
to better understand the mechanism behind the decline in the HSR in the Alzheimer’s
background. Collectively, understanding how HSF1 is being regulated in neurodegenerative
disease could provide insight into novel therapeutics to reduce or prevent the protein aggregation
associated with neurodegenerative disease.
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Methods
C. elegans strains and maintenance
The following strains were used in this study: N2 (Bristol), CL2006 - dvIs2 (pCL12(unc54/human Abeta peptide 1-42 minigene) + rol-6(su1006)), AM140 - rmIs132 (unc54p::Q35::YFP), NL5901 - pkIs2386 (unc-54p::alphasynuclein::YFP + unc-119(+)), SDW015 hsf-1(asd002(hsf-1::GFP + unc-119(+)), and SDW068. The SDW068 strain was created by
genetically crossing CL2006 with SDW015. Strains were maintained at 20°C on standard NGM
plates seeded with Escherichia coli OP50-1. The synchronous population of nematodes was
obtained by bleach synchronization and plated for 19 hrs on NGM plates without food.
RNA isolation and quantitative PCR
RNA was extracted with TRIzol® reagent (Ambion®, cat# 15,596–026) by standard protocol.
RNA was reverse transcribed using a High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, cat# 4,368,814). cDNA was diluted to 100 ng/µl to be used as a template for qRT–
PCR performed with the StepOne Plus Real‐time PCR system (Applied Biosystems, cat #
4,376,600) using iTaq™ Universal SYBR® Green Supermix (Bio‐Rad, cat# 1,725,121)
according to the manufacturer's instructions. Expression levels were analyzed via qPCR using
the ΔΔCt method. The housekeeping gene cdc-42 (R07G3.1) was used for normalization. Results
show averages of independent biological triplicates performed in technical triplicates. Statistical
analysis was performed with GraphPad (GraphPad Software, https://www.graphpad.com) using
an unpaired Student’s t-test.
Primers used: hsf-1 (Y53C10A.12) Fwd: TGCAGCCAGGATTGTCGA, Rvs:
GGCGGCGCAAAAGTCTATT; hsp16.2 (Y46H3A.3) Fwd: ACGCCAATTTGCTCCAGTCT,
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Rvs: TGATGGCAAACTTTTGATCATTGT; hsp-70 (C12C8.1) Fwd:
TTCAATGGGAAGGACCTCAACT, Rvs: GGCTGCACCAAAGGCTACTG; cdc-42
(R07G3.1) Fwd: CTTCTGAGTATGTGCCGACAGTCT, Rvs: GGCTCGCCACCGATCAT
Fluorescent microscopy
Fluorescent images were obtained using a Keyence BZ-X fluorescent microscope. Animals were
picked free of bacteria and anesthetized with 10 mM levamisole. Worms containing HSF-1::GFP
were examined in all tissue types HSF-1::GFP is present, including hypodermal, muscle,
intestinal, and germline cells (Deonarine et al., 2021).
Statistical analyses
Statistical analyses were carried out with GraphPad Software (GraphPad Software, La Jolla, CA,
USA, https://www.graphpad.com) unless otherwise stated. All error bars are representative of
standard deviation between independent biological replicates, as indicated.
Results
hsf-1 mRNA expression decreased in Alzheimer's disease model but not Huntington’s disease or
Parkinson’s disease models
Previous studies have found HSF-1 levels to be decreased in the presence of alpha-synuclein and
polyglutamine expansions in cell lines expressing these proteins. To examine the effects of
neurodegenerative disease aggregate formation on the heat shock response in C. elegans, we
utilized three widely used models of neurodegenerative disease: CL2006 - an Alzheimer’s
disease model, AM140 – a Huntington’s disease model, and NL5901 – a Parkinson’s disease
model. The Alzheimer’s model, strain CL2006, expresses a human 42-amino acid beta-amyloid

41

(Aβ1-42) peptide using a muscle-specific promoter. It forms Aβ protein aggregates with age
causing paralysis of the worm (Link, 1995). The Huntington’s model, strain AM140, expresses
one polyglutamine (polyQ) expansion of 35 glutamine residues of the Huntingtin protein using a
muscle-specific promoter tagged with YFP (Q35::YFP) (Cornaglia et al., 2016). These
Q35::YFP worms transition from soluble polyglutamine expression to aggregating
polyglutamine expression with age (Cornaglia et al., 2016). The Parkinson’s model, strain
NL5901, contains human alpha-synuclein tagged with YFP that aggregates in the muscle with
age (van Ham et al., 2008).
We examined hsf-1 mRNA levels in these neurodegenerative disease models to determine if the
presence of aggregate formation affects its expression. We isolated RNA from Day 1 and Day 6
adults in N2 (wildtype), CL2006, AM140, and NL5901 strains and measured expression of hsf-1
using RT-qPCR. We found that only in the Alzheimer’s model, CL2006, was there a significant
decrease in hsf-1 mRNA compared to wildtype on Day 1 of adulthood (Figure 3.1). We found
that levels of hsf-1 normally decrease with age in wildtype conditions; however, the levels of hsf1 remained consistent with age in all of the neurodegenerative disease models (Figure 3.1).
Overall, the levels of hsf-1 were decreased in the presence of Aβ but not in the presence of polyQ
or α-synuclein.
HSP mRNA levels increase in Alzheimer’s and Huntington’s models but not Parkinson’s model
To further examine the role of NDD aggregate formation on the HSR, we examined how the
neurodegenerative disease models affects the heat shock inducible HSF-1 target genes hsp-16.2
and hsp-70 using qRT-PCR. We found that both hsp-16.2 and hsp-70 expression was
significantly increased in the Alzheimer’s disease model compared to wildtype (Figure 3.2). hsp70 expression levels were also significantly increased in the Huntington’s disease model;
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however, hsp-16.2 levels were similar to wildtype (Figure 3.2). On the other hand, the
Parkinson’s disease model had no effect on hsp expression levels (Figure 3.2).
Visualization of HSF-1 in wildtype and Alzheimer’s disease background
Since we found significant changes to hsf-1 and HSP expression in the Alzheimer’s disease
model, we next wanted to visualize HSF-1 changes in the worm at the tissue level in the presence
of Aβ1-42. The Aβ1-42 aggregates form in only the muscle cells. Thus, we wanted to determine
tissue-specific HSF-1 changes with age in this model. To visualize HSF-1 protein levels, we
utilized an HSF-1::GFP strain, SDW015, created previously in the lab. With this strain we are
able to easily visualize HSF-1 in all tissue types, including muscle cells (Deonarine et al., 2021).
We genetically crossed the HSF-1::GFP strain with the Alzheimer’s disease model, CL2006
(Fay, 2006) to create the SDW068 strain. We utilized fluorescent microscopy to identify HSF1::GFP in all cell types, including muscle, intestinal, and germline cells, in the Aβ1-42
Alzheimer’s disease background (Figure 3.3). Here we found that HSF-1::GFP was present in all
tissue types including the muscle cells where the amyloid-beta forms. Further investigation of the
quantification of HSF-1::GFP in the muscle cells with and without the presence of amyloid-beta
would be needed. Examining HSF-1::GFP levels with age in wildtype and the amyloid-beta
background would be beneficial as the Aβ1-42 aggregates form with age.
Discussion
We sought to elucidate the effect of neurodegenerative disease on HSF-1 and HSP expression in
C. elegans. Here, we examined hsf-1 mRNA expression in an Alzheimer’s disease, Huntington’s
disease, and Parkinson’s disease model. We found that only in the presence of amyloid-beta in
the Alzheimer’s disease model did hsf-1 expression decrease. In contrast, we found that both the

43

Alzheimer’s model and the Huntington’s model had increased HSP expression. To further
examine this regulation of HSF-1 and the HSR, we created a HSF-1::GFPxAβ1-42 strain to
examine HSF-1 levels in the presence of amyloid-beta using fluorescent microscopy. Overall,
these studies suggest that neurodegenerative disease protein aggregation regulations HSF-1 and
HSR activity.
Our data suggests that hsf-1 gene expression is downregulated in the presence of amyloid-beta in
an Alzheimer’s disease model. Here we utilized whole-worm RNA isolation, but it would be
interesting to examine tissue-specific gene expression solely in tissues expressing the protein
aggregates. Understanding how HSF-1 is affected by the presence of neurodegenerative disease
protein aggregates at this level will give a better insight into its regulation of the HSR.
Examining HSF-1 regulation at the protein level would also help determine the mechanism of
neurodegenerative disease regulation. In mammals, the downregulation of HSF1 in
neurodegenerative disease is at the protein level (Gomez-Pastor et al., 2017; E. Kim et al., 2016).
Utilizing the created HSF-1::GFPxAβ1-42 strain (SDW068) can provide more insight into this
regulation in C. elegans.
While we found hsf-1 gene expression to be downregulated in the Alzheimer’s disease model,
we found that HSF-1 target genes hsp-16.2 and hsp-70 gene expression to be unregulated. This
conflict suggests that further research be performed to identify the kinetics of active HSF-1 and
if there are potentially other mechanism by which HSPs are being activated. It is possible that
other transcription factors can also activate HSPs. It will be insightful to identify if these
alternative pathways for HSP induction are being utilized as hsf-1 gene expression is being
suppressed. Overall, further studies are needed to determine the precise mechanism behind
neurodegenerative disease regulation on the HSR in C. elegans.
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Figure 3.1: hsf-1 mRNA expression decreased in Alzheimer's disease model but not Huntington’s
disease or Parkinson’s disease models. RNA was extracted from wildtype (N2), Alzheimer’s model
(AD) (CL2006), Huntington’s model (HD) (AM140), and Parkinson’s model (PD) (NL5901) worms on
Day 1 and Day 6 of adulthood. hsf-1 mRNA levels were quantified by quantitative RT-PCR (n=3
biologically independent samples). Statistical analysis was determined by determined by conducting a
One-Way ANOVA using GraphPad Prism (GraphPad Software, www.graphpad.com) followed by a
Tukey post hoc test comparison of all columns. *p-value < 0.05.
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Figure 3.2: HSP mRNA levels increase in Alzheimer’s and Huntington’s models but not
Parkinson’s model. RNA was extracted from wildtype (N2), Alzheimer’s model (CL2006),
Huntington’s model (AM140), and Parkinson’s model (NL5901) worms on Day 3 of adulthood. hsp-16.2
and hsp-70 levels were quantified by RT-PCR (n=3 biologically independent samples). Statistical analysis
was determined by determined by conducting a One-Way ANOVA using GraphPad Prism (GraphPad
Software, www.graphpad.com) followed by a Tukey post hoc test comparison of all columns. *p-value <
0.05.
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Figure 3.3: Visualization of HSF-1 in wildtype and neurodegenerative disease background. A
CRISPR strain containing HSF-1 tagged with GFP at its endogenous locus (SDW015) was crossed with
the Aβ42 Alzheimer’s disease model (CL2006). Levels of HSF-1 in wildtype worms and in the AD model
were imaged on Day 3 adults. Select cells expressing HSF-1::GFP are marked with arrows including
muscle, intestinal, and germline cells.
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CHAPTER FOUR: HSF-1 DEGRADATION VIA E3 LIGASE REGULATION IN
NEURODEGENERATIVE DISEASE IN C. ELEGANS
Abstract
The mechanism of HSF1 degradation in general, and in neurodegenerative disease in particular,
is not thoroughly characterized. Recent studies have identified two E3 ubiquitin ligases, FBXW7
and NEDD4, that target HSF1 for degradation in Huntington’s and Parkinson’s disease,
respectively. Our goal is to further elucidate the mechanism of HSF1 degradation in
neurodegenerative disease using C. elegans models. We have found that knockdown of the C.
elegans homologs for FBXW7 and NEDD4, sel-10 and Y92H12A.2, does not alter HSP reporter,
hsp-16.2p::GFP and hsp-70p::GFP, activity in the wildtype background. However, we also
examined E3 ligase knockdown in a Huntington’s disease model that expresses polyglutamine
expansions with age. In this neurodegenerative disease background, we found that sel-10 and
Y92H12A.2 RNAi increased motility and thermotolerance. Thus, both E3 ligases only regulate
the HSR in the presence of polyglutamine expansions. These studies provide more knowledge on
the regulation of HSF-1 in neurodegenerative disease, specifically Huntington’s disease, and a
potential mechanism for the decrease in HSR activity in the presence of proteotoxic aggregate
formation.
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Introduction
The heat shock response is a highly conserved cellular response to stressors that disrupt the
proteostasis of the cell. Stressors such as heat shock, heavy metals, and oxidative stress can
activate the heat shock response (HSR) (Labbadia & Morimoto, 2015). Genes encoding for
molecular chaperones are induced by heat shock transcription factor 1 (HSF1) and aid in the refolding or degradation of damaged proteins. Upon stress, HSF1 trimerizes and induces
transcription of molecular chaperones, including heat shock proteins (HSP) HSP70, HSP90, and
HSP60 (Figure 1) (Westerheide et al., 2009). These heat shock proteins guide protein folding and
degradation to equilibrate the proteostasis of the cell. Upon attenuation, HSF1 is degraded by the
ubiquitin-proteasome system (Kourtis, Moubarak, et al., 2015). The transcriptional activity of
HSF1 is stress inducible and highly regulated (Westerheide et al., 2012). The HSR is known to
play a role in a variety of physiological processes, including development, reproduction, aging,
and age-related diseases (Joutsen & Sistonen, 2019). HSF1 has been implicated in a wide array
of age-related diseases, including neurodegenerative diseases, metabolic diseases, and cancer
(Gomez-Pastor et al., 2018). Understanding HSF1 regulation with aging may be useful when
developing therapeutic strategies for such diseases.
It has been widely documented that HSF-1 and heat shock protein activity is impaired in aging
and neurodegenerative diseases (Anckar & Sistonen, 2011). Downregulation of the heat shock
response in these protein misfolding diseases contributes to the protein aggregation and overall
neuronal dysfunction and death (Gomez-Pastor et al., 2017). Many studies have found that
upregulating HSF1 or HSP activity has beneficial effects on the proteotoxicity of the diseases
(Neef et al., 2011). Previous studies have shown that HSF1 levels and HSP levels are depleted in
Alzheimer’s, Huntington’s, and Parkinson’s disease patient brains (Gomez-Pastor et al., 2017;
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Jiang et al., 2013; E. Kim et al., 2016). In Huntington’s and Parkinson’s disease, the depletion of
HSF1 is due to its degradation. Abnormal degradation of HSF1 in Huntington’s was found to be
mediated by proteasomal degradation via the E3 ligase FBXW7 (Gomez-Pastor et al., 2017).
Similarly, HSF1 phosphorylation at S303 and S307 was found to mediate this degradation by
FBXW7. HSF1 phosphorylation was found to be modified by Casein Kinase 2 (CK2). Both CK2
and FBXW7 are upregulated in Huntington’s disease (Gomez-Pastor et al., 2017). HSF1
degradation in Parkinson’s disease was found to involve the E3 ligase NEDD4, which is
upregulated in the diseased patients (E. Kim et al., 2016). Ultimately, the role of HSF1
degradation under basal conditions as well as in neurodegenerative disease has not been fully
elucidated.
Proteins needing to be sent for degradation to the proteasome are tagged with ubiquitin that is
recognized by the proteasome and where a series of enzymatic reactions is used to degrade the
targeted protein (Wang & Le, 2019). The process of ubiquitination is comprised of three
enzymes: the E1 enzyme that activates ubiquitin, the E2 molecule that binds to the ubiquitin, and
the E3 ligase that transfers the ubiquitin from the E2 molecule to the targeted protein. There are
hundreds of E3 ligases that bind to specific substrates for ubiquitin transfer (Wang & Le, 2019).
In the case of HSF1, only FBXW7 and NEDD4 are known to ubiquitinate HSF1 in the presence
of disease protein aggregation (Gomez-Pastor et al., 2017; E. Kim et al., 2016).
The activity of HSF-1, the C. elegans homolog of HSF1, is highly conserved and makes C.
elegans a useful model organism to study the regulation of HSF-1 during stress and disease.
Similarly, E3 ligases and the ubiquitin-proteasome system are highly conserved in C. elegans
(Papaevgeniou & Chondrogianni, 2014). In this study, we utilized C. elegans to examine E3
ligase regulation of the HSR in neurodegenerative disease, specifically Huntington’s disease. We
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identified a role for SEL-10 and Y92H12A.2 in negatively regulating the HSR, via motility and
thermotolerance ability, in a Huntington’s disease model in C. elegans, confirming the
importance of these regulators in this stress response pathway. Collectively, our studies
demonstrate a potential novel role for E3 ligase regulation of the HSR in neurodegenerative
disease.
Methods
C. elegans strains and maintenance
The following strains were used in this study: N2 (Bristol), TJ375 - gpIs1 (hsp-16.2p::GFP),
AM446 - (hsp-70p::GFP), and AM140 - rmIs132 (unc-54p::Q35::YFP). Strains were maintained
at 20°C on standard NGM plates seeded with Escherichia coli OP50-1. The synchronous
population of nematodes was obtained by bleach synchronization and plated for 19 hrs on NGM
plates without food.
RNA interference
Synchronous L1 nematodes were grown on standard NGM plates seeded with OP50-1 bacteria
for 19 hrs to prevent potential RNAi-mediated effects on early development. Worms were
transferred onto standard NGM plates supplemented with 25 µg/ml carbenicillin and 1 mM
isopropyl‐beta‐ᴅ‐thiogalactopyranoside (IPTG) and seeded with either HT115 bacteria
containing an empty vector (EV/L4440 control) or with sequence‐verified gene‐specific RNAi
strains isolated from the Ahringer RNAi library (J. Ahringer, University of Cambridge,
Cambridge, U.K.), as previously described (Kamath et al., 2003). To induce dsRNA production,
HT115 bacteria were supplemented with 1 mM IPTG shaking at 37°C for 1 hour before seeding.
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Fluorescent microscopy and GFP analysis
Transgenic worms containing the fluorescent reporter (TJ375 and AM446) were synchronized,
plated on RNAi plates from L1, and grown to Day 1 of adulthood. Day 1 worms were heat
shocked at 33°C for 1 hour and then recovered for 6 hours at 20°C. Animals were picked free of
bacteria and anesthetized with 10 mM levamisole. Worms were mounted onto a 3% agarose pad
and imaged using Keyence microscopy. Quantification of GFP intensity was calculated using
ImageJ (NIH) by calculating corrected total cell fluorescence (CTCF) for three trials with 20
worms/condition. Significance was determined using the student’s t-test (* p>0.05).
Thrashing assay
Thrashing/motility was tested by placing 15 Day 1 animals onto a drop of nematode growth
media (NGM) buffer on a glass slide and measuring the number of body bends/30 seconds after a
1-minute recovery period. Thrashing data reflects three biologically independent trials. Data was
plotted as boxplots using GraphPad Prism (GraphPad Software, https://www.graphpad.com) and
was analyzed with a two-tailed t test.
Thermotolerance assay
Thermotolerance was tested by exposing Day 1 animals to 37°C heat shock for 3.5 hours and
then determining survival 48 hours later by assessing response to a gentle touch. For each trial,
~100 randomly selected individual animals were assessed for the fraction alive (live/total).
Thermotolerance assay data reflects three biologically independent trials. Data was plotted as the
% survival using GraphPad Prism (GraphPad Software, https://www.graphpad.com) and was
analyzed with a two-tailed t test.
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Statistical analysis
Statistical analyses were carried out with GraphPad Software (GraphPad Software, La Jolla, CA,
USA, https://www.graphpad.com) unless otherwise stated. All error bars are representative of
standard deviation between independent biological replicates, as indicated.
Results
E3 ligase RNAi does not alter HSP reporter activity after heat stress in wildtype background
Previous studies have found that the levels of HSF-1, the regulator behind the protein quality
control machinery, are decreased in Huntington’s and Parkinson’s disease cell models (GomezPastor et al., 2017; E. Kim et al., 2016). In Huntington’s disease, mutant Huntingtin containing a
polyglutamine expansion (mHTT) increases expression of FBXW7, an E3 ligase that
ubiquitinates HSF1 for degradation (Gomez-Pastor et al., 2017). In Parkinson’s disease, the
presence of mutant α-synuclein increases expression of E3 ligase NEDD4, which ubiquitinates
HSF1 and sends it for proteasomal degradation (E. Kim et al., 2016). Depletion of HSF1 in both
diseases leads to an increase in protein aggregation and toxicity (Figure 4.1A). To examine this
regulation in C. elegans, we utilized RNAi for the respective worm homologs of these E3
ligases, sel-10 and Y92H12A.2 (Figure 4.1B).
To determine if SEL-10 and Y92H12A.2 regulate the HSR in C. elegans, we utilized the HSP
transcriptional reporter TJ375. This strain contains a transgene integrated in the genome that
utilizes the hsp-16.2 promoter to drive the expression of GFP to allow for fluorescent
quantification of hsp-16.2 activity after heat shock. We induced RNAi for EV control, sel-10
RNAi, and Y92H12A.2 RNAi 19 hours after the L1 stage until Day 1 of adulthood, when we
heat shocked the worms for 1 hour at 33°C and subsequently allowed recovery for 6 hours. We
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measured GFP fluorescence of non-heat shocked and heat shocked worms. We found that
compared to control, SEL-10 and Y92H12A.2 did not significantly alter hsp-16.2 reporter
activity in the wildtype background (Figure 4.2).
Similarly, we also used the HSP transcriptional report AM446, which utilizes the hsp-70
promoter to drive GFP expression. We quantified GFP fluorescence before and after heat shock
with sel-10 and Y92H12A.2 RNAi using the same conditions. We also found that sel-10 and
Y92H12A.2 knockdown did not significantly change hsp-70 reporter activity in the wildtype
background (Figure 4.3). Overall, E3 ligase RNAi did not affect HSP reporter activity in the
wildtype background.
E3 ligase RNAi enhances motility in polyQ Huntington’s disease model
We next wanted to examine SEL-10 and Y92H12A.2 regulation in a neurodegenerative disease
background to determine if the presence of the protein aggregate toxicity of the disease model
attributes to the regulation of the HSR. We utilized a Huntington’s disease model, AM140, that
expresses one polyglutamine (polyQ) expansion of 35 glutamine residues of the Huntingtin
protein using a muscle-specific promoter tagged with YFP (Q35::YFP) (Cornaglia et al., 2016).
These Q35::YFP worms transition from soluble polyglutamine expression to aggregating
polyglutamine expression with age (Cornaglia et al., 2016). We examined motility in aged
worms on Day 3 of adulthood where polyQ aggregates have formed. We found that RNAi of sel10 and Y92H12A.2 significantly increased motility in the Huntington’s disease background
(Figure 4.4).
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E3 ligase RNAi increases thermotolerance in polyQ Huntington’s disease model
We then wanted to test whether CBP-1 also regulates other physiological readouts of the HSR.
To test for resistance to heat stress, we examined thermotolerance, a physiological effect known
to be modulated by HSF-1. To test this, we fed the worms sel-10, Y92H12A.2, or control RNAi
from 19 hrs after L1 until Day 3 of adulthood prior to subjecting the worms to a lethal heat shock
of 37⁰C for 3.5 hours. After a 48-hour recovery, the worms were scored alive/dead after a gentle
touch. We examined thermotolerance in the N2 wildtype background and in the Huntington’s
disease model background. In wildtype worms, compared to empty vector control RNAi-treated
worms, sel-10 and Y92H12A.2 RNAi worms had similar % survival after heat (Figure 4.5).
However, in the Huntington’s disease model, sel-10 and Y92H12A.2 RNAi worms has
significantly increased survival compared to control worms (Figure 4.5). Thus, only in the
Huntington’s disease background was there and increase in survivability after severe heat stress
under E3 ligase knockdown.
Discussion
Given the importance of HSF-1 degradation in neurodegenerative disease, we sought to elucidate
the effect of E3 ligase regulation on the HSR. Here, we examined HSP reporter activity under E3
ligase knockdown and found that SEL-10 and Y92H12A.2 did not alter HSP activity in the
wildtype background. In addition, we examined E3 ligase knockdown in a Huntington’s disease
background and found that sel-10 and Y92H12A.2 RNAi increased motility and
thermotolerance. Overall, these studies suggest a role for SEL-10 and Y92H12A.2 in negatively
regulating HSF-1 activity specifically in the Huntington’s disease background.
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Our data suggests that the E3 ligases SEL-10 and Y92H12A.2 negatively regulate the HSR only
in the presences of Huntington’s disease polyglutamine protein aggregates. However, further
work is needed to elucidate the full scope of their regulation. It is unclear if either E3 ligase
directly ubiquitinates HSF-1, leading to its degradation. Are these E3 ligases directly regulating
HSF-1 through ubiquitination or through an axillary mechanism? Similarly, can we see a similar
negative regulation in other neurodegenerative disease backgrounds? Uncovering these answers
will give a better understanding of if the HSF-1 degradation mechanism of neurodegenerative
diseases is conserved in C. elegans. Further studies are needed to examine overall E3 ligase
regulation of HSF-1 and the HSR in C. elegans.
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Figure 4.1: Overview of HSF-1 depletion in neurodegenerative disease. A) In healthy cells, the heat
shock response activates when under proteotoxic stress via activation of heat shock transcription factor 1
(HSF1). In Huntington’s disease, mutant Huntingtin containing a polyglutamine expansion (mHTT)
increases expression of FBXW7, an E3 ligase that ubiquitinates HSF1 for degradation (Gomez-Pastor et
al., 2017). In Parkinson’s disease, the presence of mutant α-synuclein increases expression of E3 ligase
NEDD4, which ubiquitinates HSF1 and sends it for proteasomal degradation (E. Kim et al., 2016).
Depletion of HSF1 in both diseases leads to an increase in protein aggregation and toxicity. B) List of E3
ligases known to ubiquitinate HSF1 and their C. elegans homologs.
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Figure 4.2: E3 ligase RNAi does not alter hsp-16.2 reporter activity after heat stress in wildtype
background. TJ375 (phsp-16.2::GFP) worms were grown on EV, sel-10, or Y92H12A.2 RNAi until Day
1 of adulthood. Worms were then exposed to a 1-hour heat shock at 33°C and then recovered for 6 hours
at 20°C. Approximately 20 worms were anesthetized with 10mM levamisole and imaged using
fluorescent microscopy. GFP fluorescence was quantified using ImageJ (NIH). Experiment was
conducted in biological triplicate and statistics were analyzed using GraphPad Prism (GraphPad Software,
www.graphpad.com) and was analysed with a two-tailed t test. *p-value < 0.05.
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Figure 4.3: E3 ligase RNAi does not alter hsp-70 reporter activity after heat stress in wildtype
background. AM446 (phsp-70::GFP) worms were grown on EV, sel-10, or Y92H12A.2 RNAi until Day
1 of adulthood. Worms were then exposed to a 1-hour heat shock at 33°C and then recovered for 6 hours
at 20°C. Approximately 20 worms were anesthetized with 10mM levamisole and imaged using
fluorescent microscopy. GFP fluorescence was quantified using ImageJ (NIH). Experiment was
conducted in biological triplicate and statistics were analyzed using GraphPad Prism (GraphPad Software,
www.graphpad.com) and was analysed with a two-tailed t test. *p-value < 0.05.
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Figure 4.4: E3 ligase RNAi enhances motility in polyQ Huntington’s disease model. Motility of the
AM140 Huntington’s strain under EV, Y92H12A.2 or sel-10 RNAi was measured by placing Day 3
worms in a drop of NGM buffer and counting the number of thrashes in 30 seconds after a 1-minute
recovery period(n=~15 worms). Thrashing assay was conducted in biological triplicate and statistics were
analyzed using GraphPad Prism (GraphPad Software, www.graphpad.com) and was analyzed with a twotailed t test. *p-value < 0.05.
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Figure 4.5: E3 ligase RNAi increases thermotolerance in polyQ Huntington’s disease model.
Thermotolerance of the wildtype (N2) strain and the Huntington’s disease (AM140) strain was measured
by subjecting the worms to a severe heat shock at 37 °C for 2 hours and measuring survival after a 24hour recovery. Percent survival was determined for worms fed with empty vector (EV), Y92H12A.2, and
sel-10 RNAi. Data was plotted as % survival using GraphPad Prism (GraphPad Software,
www.graphpad.com) and was analyzed with a two-tailed t test. *p-value < 0.05.
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CHAPTER FIVE: IMPLICATIONS AND FUTURE DIRECTIONS
Implications
CBP-1 regulation of the HSR
Our results indicate that CBP-1 negatively regulates the heat shock response and HSF-1 activity
in C. elegans. However, there are many unanswered questions about this regulation that remain
unresolved. For example, the mechanism behind CBP-1 regulation is far from being elucidated.
Does CBP-1 utilize its acetyltransferase activity to directly acetylate HSF-1 or is there an indirect
mechanism by which CBP-1 controls HSF-1 activity? It is known that CBP-1 in C. elegans
regulates other stress response transcription factors, however, it is unclear if CBP-1
acetyltransferase activity is required for this regulation (Ganner et al., 2019; T. Y. Li et al.,
2021). Understanding how CBP-1 regulates HSF-1 will give us potential insight into how HSF-1
and other stress response transcription factors may be influenced by lysine acetyltransferases.
Additionally, we found that CBP-1 knockdown increases the recovery rate of nuclear stress
bodies. The overall function of nuclear stress bodies is still an outstanding question in the
literature. Recent studies suggest the resolution of nSBs correlates with HSF1 activity,
transcription of hsp target genes, and cell survival at the single cell level (Gaglia et al., 2020). A
recent mammalian study discovered the existence of both HSF1 nSBs at non-hsp gene loci and
smaller HSF1 condensates at transcriptionally active hsp gene loci upon heat shock (H. Zhang et
al., 2022). How CBP-1 plays a role in the functionality of nuclear stress bodies, not just via HSF1, could give us insight into the overall function of nuclear stress bodies as a whole. As well, we
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examined CBP-1 regulation on nSBs in hypodermal cells, but it may also be important to
examine other tissue types. HSF-1 expression and localization is distinct between certain tissue
types (Deonarine et al., 2021). Understanding CBP-1 regulation in a tissue-specific manner could
reveal more about its function in nuclear stress bodies.
HSR regulation in neurodegenerative disease
Our data suggests that hsf-1 gene expression is downregulated in the presence of amyloid-beta in
an Alzheimer’s disease model. Here we utilized whole-worm RNA isolation, but it would be
interesting to examine tissue-specific gene expression solely in tissues expressing the protein
aggregates examining. Understanding how HSF-1 is affected by the presence of
neurodegenerative disease protein aggregates at this level will give a better insight into its
regulation of the HSR. Examining HSF-1 regulation at the protein level would also help
determine the mechanism of neurodegenerative disease regulation. In mammals, the
downregulation of HSF1 in neurodegenerative disease is at the protein level (Gomez-Pastor et
al., 2017; E. Kim et al., 2016). Utilizing the created HSF-1::GFPxAβ1-42 strain (SDW068) can
provide more insight into this regulation in C. elegans.
While we found hsf-1 gene expression to be downregulated in the Alzheimer’s disease model,
we found that HSF-1 target genes hsp-16.2 and hsp-70 gene expression to be unregulated. This
conflict suggests that further research be performed to identify the kinetics of active HSF-1 and
if there are potentially other mechanism by which HSPs are being activated. It is possible that
other transcription factors can also activate HSPs. It will be insightful to identify if these
alternative pathways for HSP induction are being utilized as hsf-1 gene expression is being
suppressed.
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HSF-1 degradation in neurodegenerative disease
Our data suggests that the E3 ligases SEL-10 and Y92H12A.2 negatively regulate the HSR only
in the presences of Huntington’s disease polyglutamine protein aggregates. However, further
work is needed to elucidate the full scope of their regulation. It is unclear if either E3 ligase
directly ubiquitinates HSF-1, leading to its degradation. Are these E3 ligases directly regulating
HSF-1 through ubiquitination or through an axillary mechanism? Similarly, can we see a similar
negative regulation in other neurodegenerative disease backgrounds? Uncovering these answers
will give a better understanding of if the HSF-1 degradation mechanism of neurodegenerative
diseases is conserved in C. elegans. With this insight, we can further examine other E3 ligase
regulation of HSF-1 and the HSR through the ease of RNAi screening in C. elegans.
Future Study 1: Mechanism of CBP-1 regulation of the heat shock response
Identifying the mechanism of CBP-1 regulation on the heat shock response has large appeal. We
found that CBP-1 negatively regulates HSP expression, nuclear stress body recovery, and
thermotolerance ability of the worm. Thus, future work is needed to determine the precise
mechanism of action of CBP-1 in the HSR pathway and any potential acetylation changes of
HSF-1 that are induced by CBP-1, given its acetyltransferase function. Specifically, does CBP-1
regulate HSF-1 binding to promotors? Does CBP-1 acetylate HSF-1? To answer these questions,
we could utilize our HSF-1::GFP to perform chromatin-immunoprecipitation (Ch-IP) to
determine if CBP-1 alters the activation of HSF-1 and its ability to bind to its target promoters
after heat stress. Similarly, we could perform co-immunoprecipitation (Co-IP) to pull down HSF1 and utilize mass spectrometry to identify HSF-1 acetylation changes with and without cbp-1
RNAi. It would also be interesting to identify HSF-1 binding partners via Co-IP and mass
spectrometry. It is unknown if HSF-1 and CBP-1 directly bind. Overall, the mechanism of CBP64

1 regulation on the HSR is not fully elucidated and examining HSF-1 protein levels with CBP-1
would be an interesting future study to uncover CBP-1’s mechanism of action in the HSR.
Future Study 2: HSF-1 and nuclear stress body changes in neurodegenerative disease
To visualize HSF-1 protein levels with age in the Alzheimer’s disease model, we have
genetically crossed the SDW015 strain containing endogenously expressed HSF-1::GFP with the
Alzheimer’s model, strain CL2006, which expresses a 42-amino acid beta-amyloid peptide using
a muscle-specific promoter that forms protein aggregates with age causing paralysis of the worm
(Link, 1995) (Figure 3.3). Using this crossed strain, future experiments could be performed to
visualize HSF-1 protein levels in the presence of Aβ in a tissue-specific manner. The
fluorescently tagged HSF-1 will allow us to visualize changes in HSF-1 levels as the disease
protein aggregates with age via fluorescence microscopy. Since the protein aggregates in the
Alzheimer’s disease model are localized to the muscle cells, one could compare HSF-1 levels in
tissues with and without the disease protein aggregates. This would allow visualization of the
tissue-specificity of HSR regulation in the Alzheimer’s disease model and determination of how
Aβ can influence HSF-1 in a tissue-specific manner.
With this HSF-1::GFP strain, we could also examine the formation and resolution of nuclear
stress bodies (Deonarine et al., 2021). Nuclear stress body behavior in neurodegenerative disease
has not been examined, thus utilizing this crossed strain to examine nSBs in the presence of Aβ
would be of interest. Our previous work has uncovered a regulator of nSB resolution, CBP-1. It
would be interesting to examine how the disease state can alter this regulation as well.
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Future Study 3: Targeted-RNAi screen for E3 ligase regulators of HSF-1
Previously, two E3 ligases, FBXW7 and NEDD4 respectively, were found to play a role in HSF1 degradation in Huntington’s and Parkinson’s disease mouse and cell models. FBXW7 was
tested due to its connection to HSF-1 in Huntington’s polyglutamine expansion brain cells, and
NEDD4 was found to be increased in Parkinson’s patients previously (Gomez-Pastor et al.,
2017; E. Kim et al., 2016). Since both were hand-picked and not the result of a large-scale screen
of E3 ligases, we hypothesize that there are other E3 ligases that play a role in the
neurodegenerative disease-induced degradation of HSF-1.
To identify these E3 ligases, one could utilize RNAi against the E3 ligases in the C. elegans
genome (Ohkumo, Masutani, Eki, & Hanaoka, 2008). There are 171 genes in the C. elegans
genome that encode proteins containing one of the following E3 ligase domains: HECT-domain,
U-box domain, monomeric RING finger domain, or multi-subunit complexes that contain a
RING finger domain (Fang, Lorick, Jensen, & Weissman, 2003; Medvar, Raghuram, Pisitkun,
Sarkar, & Knepper, 2016). FBXW7 and NEDD4 are conserved in the worm and can be included
in the RNAi-targeted screen (J. Li et al., 2002; Maeda, Kohara, Yamamoto, & Sugimoto, 2001).
We compiled a list of all E3 ligases with their known human homologs (Table B1/2/3/4). We
could conduct an RNAi-targeted screen where RNAi is induced at the L4 developmental stage
and grow the worms until Day 4 of adulthood in a 96-well plate format (Lehner, Tischler, &
Fraser, 2006). We could grow the worms in the RNAi culture until Day 3 of adulthood when the
disease protein aggregates usually begin to fully form in the disease model strains (Ohkumo et
al., 2008). Once the E3 ligases that degrade HSF-1 are identified, we could visualize changes in
protein aggregation upon age with and without RNAi against the ligases. The goal is to evaluate
the effects the specific E3 ligases have on the progression of the protein aggregation in the
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neurodegenerative disease models. Overall, it would be interesting to identify the full scope of
E3 ligase regulation on the HSR and HSF-1 in C. elegans.
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APPENDIX A: SUPPLEMENTAL FIGURES FOR CHAPTER TWO

Figure A1: Validation of hsf-1 RNAi. RNA was extracted from wildtype (N2) worms on Day 1 of
adulthood that were fed empty vector (EV), cbp-1, or hsf-1 RNAi beginning 19 hrs after L1. cbp-1 and
hsf-1 levels were quantified by qRT-PCR (n = 3 biologically independent samples). Statistical analysis
determined by determined by conducting a One-Way ANOVA using GraphPad Prism (GraphPad
Software, www.graphpad.com) followed by a Tukey post hoc test comparison of all columns. *p-value <
0.05, **p-value < 0.01, ***p-value < 0.001.
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Figure A2: Validation of KAT RNAi. RNA was extracted from N2 worms on Day 1 of adulthood that
were fed EV or KAT RNAi beginning 19 hrs after L1. Validation of KAT knockdown was examined by
quantifying KAT levels by qRT-PCR (n = 3 biologically independent samples). Statistical analysis
determined by determined by conducting a One-Way ANOVA using GraphPad Prism (GraphPad
Software, www.graphpad.com) followed by a Tukey post hoc test comparison of all columns. *p-value <
0.05, **p-value < 0.01, ***p-value < 0.001.
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Figure A3: cbp-1 RNAi does not change the expression of HSF-1 target genes under basal
conditions. A) RNA was extracted from N2 (wildtype) worms on Day 1 of adulthood under basal
conditions at 20°C that were fed empty vector (EV), cbp-1, or hsf-1 RNAi beginning 19 hrs after L1. Heat
shock inducible heat shock protein gene expression levels for hsp-16.2, hsp-16.48, F44E5.5, and hsp-70
were quantified by qRT-PCR. B) RNA was extracted from N2 worms on Day 1 of adulthood under basal
conditions that were fed EV or cbp-1 RNAi beginning 19 hrs after L1. Developmental HSF-1 target genes
independent of the heat shock response, hsp-1 and hsp-90, were quantified by qRT-PCR. Statistical
analysis was determined by determined by conducting a One-Way ANOVA using GraphPad Prism
(GraphPad Software, www.graphpad.com) followed by a Tukey post hoc test comparison of all columns.
*p-value < 0.05.
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Table A1: Lifespan analysis of cbp-1 RNAi. Analysis of lifespan of EV, cbp-1, hsf-1, and cbp-1/hsf-1
RNAi including mean lifespan and total/censored/scored number of worms per trial (done in biological
triplicate). Survivability was plotted using OASIS 2 (https://sbi.postech.ac.kr/oasis2/) (Han et al. 2016),
and statistical analysis was done by Log-rank (Mantel-Cox) Test.
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APPENDIX B: SUPPLEMENTAL TABLES FOR CHAPTER FIVE
Table B1: List of HECT domain E3 ligases in C. elegans

Sequence

C. elegans E3 ligase

C34D4.14
D2085.4

hecd-1
etc-1

F36A2.13

ubr-5

F45H7.6
hecw-1
Y39A1C.2
oxi-1
Y48G8AL.1 herc-1
Y65B4BR.4

wwp-1

Y67D8C.5

eel-1

Y92H12A.2

-

Human Homolog
Hect domain E3s
HECTD1 (HECT domain E3 ubiquitin protein ligase 1)
UBE3C
UBR5 (ubiquitin protein ligase E3 component n-recognin
5)
HECW1 and HECW2 (HECT, C2 and WW domain
containing E3 ubiquitin protein ligase 1)
UBE3B
HERC3, HERC4, and HERC6
ITCH (itchy E3 ubiquitin protein ligase), WWP1 (WW
domain containing E3 ubiquitin protein ligase 1)
HUWE1 (HECT, UBA and WWE domain containing 1,
E3 ubiquitin protein ligase)
NEDD4L (neural precursor cell expressed,
developmentally down-regulated 4-like, E3 ubiquitin
protein ligase) and NEDD4
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Table B2: List of Cullin-based E3 ligases in C. elegans

Sequence

C. elegans E3 ligase

D2045.6
ZK520.4
Y108G3AL.1
F45E12.3
ZK856.1
K08E7.7

cul-1
cul-2
cul-3
cul-4
cul-5
cul-6

K10B2.1
F55B12.3
C26E6.5

lin-23
sel-10
fsn-1

Human Homolog
Cullin-based E3s
CUL1
CUL2
CUL3
CUL4
CUL5
CUL1
BTRC (beta-transducin repeat containing E3 ubiquitin
protein ligase) and FBXW11 (F-box and WD repeat
domain containing 11)
FBXW7 (F-box and WD repeat domain containing 7)
FBXO45 (F-box protein 45)

Table B3: List of U-box E3 ligases in C. elegans

Sequence
F59E10.2
T05H10.5
T09B4.10
T10F2.4

C. elegans E3 ligase

ufd-2
chn-1
prp-19

Human Homolog
U-box E3s
PPIL2
UBE4B
STUB1
PRPF19 (pre-mRNA processing factor 19)
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Table B4: List of monomeric ring finger E3 ligases in C. elegans

Sequence

C. elegans E3 ligase

Human Homolog

Monomeric Ring Finger E3s
B0281.3
B0281.8
B0393.6
B0416.4
B0432.13
C01B7.6
C01G6.4
C02B8.6
C06A5.8
C06A5.9
C09E7.5
C09E7.8
C09E7.9
C11H1.3
C12C8.3
C15F1.5
C16C10.5
C16C10.7
C17E4.3
C17H11.6
C18B12.4
C18H9.7
C26B9.6
C28G1.5
C28G1.6
C30F2.2
C32D5.10
C32D5.11
C32E8.1
C34E10.4
C34F11.1
C36A4.8
C36B1.9
C39F7.2
C45G7.4
C49H3.5
C52E12.1
C53A5.6

rpm-1, rpm-3, sam-1, sad-3,
syd-3
rnf-1, tag-54
lin-41
rnf-121
rnf-5
marc-3
rpy-1, rap-1
prx-10, wrs-2, wars-2
brc-1
madd-2
ntl-4
-

TRAIP
MYCBP2
RNF11

MGRN1, RNF157
TRIM71
RNF121, RNF175
RNF185
MARCH2, MARCH3
RNF19A, RNF19B
RNF13, RNF167, ZNRF4
RAPSN

WARS2
Brca1

CNOT4
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Table B4 (cont.)
Sequence

C. elegans E3 ligase

Human Homolog
Monomeric Ring Finger E3s

C53D5.2
C55A6.1
C56A3.4
D2089.2
EEED8.16
F08B12.2
F08G12.5
F10D7.5
F10G7.10
F11A10.3
F16A11.1
F19G12.1
F23B2.10
F26E4.11
F26F4.7
F26G5.9
F32A6.3
F35G12.9
F36F2.3
F40G9.12
F40G9.14
F42C5.4
F42G2.5
F43C11.7
F43C11.8
F43G6.8
F44D12.10
F45G2.6
F46F2.1
F47G9.4
F53F8.3
F53G2.7
F54B11.5

marc-4
marc-2
brap-2
prx-12
mig-32
hrdl-1
nhl-2
tam-1
vps-41
apc-11
rbpl-1
trf-1
mnat-1
-

F54G8.4
F55A3.1
F55A11.3
F55A11.7

nhl-1
marc-6
sel-11
-

RNF146
MARCH2
BRAP
PEX12
NEURL1, NEURL1B
UBR3
PCGF3
RSPRY1

AMFR (autocrine motility factor receptor)

VPS41
ANAPC11 (anaphase promoting complex subunit 11)
RBBP6 (RB binding protein 6, ubiquitin ligase)

VAPA, VAPB

TRAF4 (TNF receptor associated factor 4)
RNF207 (ring finger protein 207)
MNAT1 (MNAT1, CDK activating kinase assembly factor)
RNF141 (ring finger protein 141)
TRIM2 (tripartite motif containing 2), TRIM3 (tripartite
motif containing 3)
MARCH6 (membrane associated ring-CH-type finger 6)
SYVN1 (synoviolin 1)
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Table B4 (cont.)
Sequence

C. elegans E3 ligase

F56D2.2
F58B6.3
F58E6.1
H05L14.2
H10E21.5

par-2
sta-2
-

K01G5.1
K02B12.8
K04C2.4
K09F6.7
K11D12.9
K12B6.8

rnf-113
zhp-3
brd-1
-

M02A10.3
M88.3
M110.3

sli-1
-

M142.6
R02E12.4

rle-1
-

R05D3.4
R06F6.2
R10A10.2
T01C3.3
T01G5.7
T02C1.1
T02C1.2
T05A12.4
T08D2.4
T13A10.2
T13H2.5
T20F5.6
T20F5.7
T22B2.1
T23F6.3
T24D1.2
T24D1.3
T24D1.5

rfp-1
vps-11
rbx-2
spat-3
har-2

Human Homolog

Monomeric Ring Finger E3s
RNF14 (ring finger protein 14)

RNF148 (ring finger protein 148), RNF149, and RNF150
RNF113A (ring finger protein 113A) and RNF113B (ring
finger protein 113B)
RNF212B (ring finger protein 212B)

CBL (Cbl proto-oncogene), CBLB (Cbl proto-oncogene B),
and CBLC (Cbl proto-oncogene C)

RC3H1 (ring finger and CCCH-type domains 1) and RC3H2
(ring finger and CCCH-type domains 2)
TEKT4 (tektin 4)
RNF20 (ring finger protein 20) and RNF40 (ring finger
protein 40)
VPS11 (VPS11, CORVET/HOPS core subunit)
RNF7 (ring finger protein 7)

SHPRH (SNF2 histone linker PHD RING helicase)
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Table B4 (cont.)
Sequence

C. elegans E3 ligase

Human Homolog

Monomeric Ring Finger E3s
T26C12.3
W02A11.3
W04H10.3
W09G3.6
Y4C6A.3
Y6D1A.2
Y7A9C.1
Y38C1AA.6
Y38F1A.2
Y38H8A.2
Y45F10B.8
Y45F10B.9
Y45G12B.2
Y47D3A.22
Y47D3B.11
Y47G6A.14
Y51F10.2
Y52E8A.2
Y53G8AM.4
Y54E10A.11
Y54E10BR.3
Y55F3AM.6
Y57A10B.1
Y67D8B.1
Y71F9AL.10
Y73C8C.7
Y73C8C.8
Y75B8A.10
Y105C5B.11
Y105E8A.14
Y119C1B.5

toe-4
nhl-3
mib-1
plr-1
lep-2
marc-5
sdz-34
rnf-145

ZC13.1
ZK287.5
ZK637.14
ZK809.7
ZK993.2
ZK1240.1

rbx-1
prx-2
-

RNF111 (ring finger protein 111)

RNF170 (ring finger protein 170)

ZFPL1
MIB1 (mindbomb E3 ubiquitin protein ligase 1)

LTN1 (listerin E3 ubiquitin protein ligase 1)
RNF115 (ring finger protein 115) and RNF126

ZNRF1 (zinc and ring finger 1)

RNF146 (ring finger protein 146)
RNF145 (ring finger protein 145)
RNFT1 (ring finger protein, transmembrane 1) and RNFT2
(ring finger protein, transmembrane 2)
RBX1 (ring-box 1)
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Table B4 (cont.)
Sequence

C. elegans E3 ligase

Human Homolog
Monomeric Ring Finger E3s

ZK1240.2
ZK1240.3
ZK1240.6
ZK1240.8
ZK1240.9
ZK1320.6

arc-1, arl-4

TRIM23 (tripartite motif containing 23)
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APPENDIX C: EXTENDED PROTOCOLS
Bleach Synchronization
1. Prep: One 15ml tube and 2 transfer pipets per strain
2. Examine plate for high percentage of gravid adults. If there are no eggs or bacteria on the
plate, it is probably starved and should not be used for your experiment.
3. Take out clean NGM plate to warm to room temperature.
4. Wash plate with NGM buffer, use a transfer pipet to pipet worms into a 15 mL tube,
repeat plate wash until most of the worms have been removed.
5. Cap tightly, invert 3-4 times, and centrifuge at 1600 rpm for 30 seconds (or allow to sit
undisturbed in rack for ~5-7 minutes to gravity settle out the adults).
6. Discard supernatant which contains excess bacteria + larval worms.
7. Wash adults with up to 10 mL of H20 and centrifuge at 1600 rpm for 30 seconds (or
allow them to gravity settle again for ~5-7 minutes). You should have a clear supernatant
now. If not, rewash with H20 until clean.
8. Remove supernatant to 3.5 mL. Discard transfer pipet.
The rest of the procedure must be done to completion. Take a break now if needed.
9. Quickly add 1000 µL of bleach then 250 µL of NaOH to worms. Cap tube tightly, and
continuously and vigorously shake for a maximum of 5 minutes. Worms will typically by
lysed around 3-4 minutes.
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10. Examine tube for unlysed worm bodies, if you observe no bodies prior to 5 minutes move
on to the next step, but no matter what do not lyse for longer than 5 minutes or eggs will
begin to be destroyed.
11. After the 5 min bleach, add H20 up to 10 mL and centrifuge tube at 1600 rpm for 30
seconds. Carefully pipet out supernatant using the second transfer pipet, not to disturb the
egg pellet.
12. Pour up to 5 mL of H20 to the tube. This should resuspend the eggs into the solution.
Centrifuge at 1600 rpm for 30 seconds and remove the supernatant.
13. Repeat step 11 once more to ensure you have removed all the bleach. Leave ~0.5ml of
supernatant in the tube.
14. Use the transfer pipet to break up egg clumps (blow bubbles and gently pipet up and
down a few times) and resuspend the eggs, then transfer the eggs to a clean NGM plate.
15. Observe plate for clean vs. messy bleach (only eggs vs. eggs and dead bodies).
16. Dry plate in sterile hood, wrap in parafilm, and place in incubator to hatch overnight.

Nematode Growth Media (NGM) Plate Protocol
1. Add H20, NaCl, Peptone, and Agar using the attached plate recipes to the appropriate
size bottle (do not autoclave bottles more than half full). Add stir bar and mix on stir plate
until dissolved.
2. Autoclave on liquid 30 or liquid 45 setting depending on the amount of liquid being
autoclaved. The cap MUST be loose. Make sure to add a piece of autoclave tape onto the
bottle before autoclaving.
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3. Place the bottle on a hot plate at ~75 degrees with stirring to keep the media at the correct
temperature until you are ready to pour. When ready to pour, the media temperature
should be at ~55C (you should be able to hold your hand on the bottle for 5-10 seconds
without it being too hot).
4. Add the MgSO4, CaCl2, cholesterol, KH2PO4, and any additional antibiotics using the
attached recipes and stir on hot plate.
5. Pipette out 25 ml of the media onto 100mm plates or 10 ml of media onto 60mm plates.
6. Allow to dry overnight at room temperature on the bench before seeding.
7. To seed, add 200 ml of the appropriate bacteria culture to the 100mm plates or 100 ml to
the 60mm plates.
8. Spread bacteria using the metal spreader and allow the bacteria to dry overnight at room
temperature on the bench.
9. Place the plates in a plastic container or tied and sealed with tape into the plastic sleeve
the plates come in. Place them in the 4C fridge/cold room for storage (Plates can be
stored at 4C for approximately 1 month).

NGM Plates
# of 100mm Plates
H20 (mL)
NaCl (g)
Peptone (g)
Agar (g)
Add stir bar and autoclave
Cool to 55°C then
aseptically add:
MgSO4 (µL)
CaCl2 (µL)
Cholesterol (µL)
KH2PO4 (mL)

8
200
0.6
0.5
3.4

16
400
1.2
1
6.8

24
600
1.8
1.5
10.2

32
40
800 1000
2.4
3
2
2.5
13.6
17

200
200
200
5

400
400
400
10

600
600
600
15

800 1000
800 1000
800 1000
20
25
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OP50-1 Plates
# of 100mm Plates
H20 (mL)
NaCl (g)
Peptone (g)
Agar (g)
Add stir bar and autoclave
Cool to 55°C then
aseptically add:
MgSO4 (µL)
CaCl2 (µL)
Cholesterol (µL)
KH2PO4 (mL)
Streptomycin (uL)

8
200
0.6
0.5
3.4

16
400
1.2
1
6.8

24
600
1.8
1.5
10.2

32
40
800 1000
2.4
3
2
2.5
13.6
17

200
200
200
5
200

400
400
400
10
400

600
600
600
15
600

800
800
800
20
800

8
200
0.24
4
5

16
400
0.48
8
10

24
600
0.72
12
15

32
40
800 1000
0.96
1.2
16
20
20
25

200
200
200
5

400
400
400
10

600
600
600
15

800 1000
800 1000
800 1000
20
25

1000
1000
1000
25
1000

NA22 Plates
# of 100mm Plates
H20 (mL)
NaCl (g)
Peptone (g)
Agar (g)
Add stir bar and autoclave
Cool to 55°C then
aseptically add:
MgSO4 (µL)
CaCl2 (µL)
Cholesterol (µL)
KH2PO4 (mL)
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RNAi Plates
# of 100mm Plates
H20 (mL)
NaCl (g)
Peptone (g)
Agar (g)
Add stir bar and autoclave
Cool to 55°C then
aseptically add:
MgSO4 (µL)
CaCl2 (µL)
Cholesterol (µL)
Carb (µL)
IPTG (µL)
OR 20% Lactose (mL)
KH2PO4 (mL)

8
200
0.6
0.5
3.4

16
400
1.2
1
6.8

24
600
1.8
1.5
10.2

32
40
800 1000
2.4
3
2
2.5
13.6
17

200
200
200
200
200
2
5

400
400
400
400
400
4
10

600
600
600
600
600
6
15

800
800
800
800
800
8
20

1000
1000
1000
1000
1000
10
25

Worm Picking
1. Sterilize the metal pick using a flame and keep the flame near the microscope to prevent
airborne contamination.
2. Pick up a small amount of bacteria onto your pick and use the sticking or scooping
method to pick up the worm and transfer it from one plate to another.
3. Do not allow a worm to sit on the pick for more than 30-60 secs or it will dry up and die.
Be very gentle when using the metal pick as to not damage the worm during the process.
4. Gently place the worm on the new plate, being careful not to dig into the agar. Placing
the worm outside of the bacteria lawn and straight on the agar makes it easier to remove
the worm off of the pick.
5. Re-flame the pick periodically to remove excess bacteria and prevent contamination.
Always re-flame pick after each strain to prevent cross contaminating your worm strains.
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6. If using a hair pick, spray or dip the pick in ethanol to clean (it will never be perfectly
sterile) and use it to transfer worms.
7. Note: Every pick behaves differently, and you will need to play around with your own
personal picking technique. Practice, practice, practice.

Worm Chunking
1. Take out fresh plate (OP50 or NA22) to warm up to room temperature.
2. Light Bunsen burner and wear gloves.
3. Spray metal spatula with 70% ethanol and pass-through flame 3-4 times to sterilize the
end. Allow spatula to cool for 10-15 seconds.
4. Cut out a small 1 cm cube of agar from the source plate and transfer it “worm side” down
to the new plate.
5. Use the spatula to scrape the worm side of the chunk across the plate to spread out the
worms.
6. Observe under the microscope for worms on the new plate, rechunk if none are seen or
all worms are dead.
7. Wrap plate with parafilm and place in incubator.
8. Note: Chunking is a non-sterile procedure so if your source plate is heavily contaminated,
the new plate will also become contaminated. If the worms are particularly sick you may
want to consider doing a bleach prep in the future to clean the strain up.
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Worm Freezing
1. Bring freezing chamber to room temp and ensure it is appropriately filled with isopropyl
alcohol.
2. Prepare 5 replicate cryovials per strain you wish to freeze. On the side of each cryovial,
label it with the strain name, date frozen, your initials, and tube # (ex. 1/5, 2/5, 3/5, etc).
On the top of each tube, label with just the strain name.
3. Allow an OP50 plate to completely starve out. Ideally, you’ll end up with a population
consisting of ~10-20,000 of starving L1 and L2 animals with a few adults. Older worms
do not survive the freezing process well.
a. Note: If plates are heavily contaminated, bleach and allow to restarve.
4. Chunk some of each strain to a fresh OP50 plate in case the freezing recovery goes
poorly.
5. Wash the rest of each plate into a 15 ml tube with NGM buffer.
6. Repeat wash step until supernatant becomes clear. And then remove supernatant leaving
2.5 ml of NGM in tube.
7. Add 2.5 ml worms freezing media and mix thoroughly.
8. Resuspend worms evenly using the pipet, then pipet 1 ml into each of the cyrovials.
9. Place all cryovials to be frozen in the freezing chamber and immediately place in -80C.

Worm Thawing
1. Remove cryovial of your strain of interest. Hold the tube in your hand to quickly warm it
up.
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2. In the sterile hood, once thawed, mix the tube carefully and pipet the worms onto OP50
plates.
3. Let the plates dry completely, wrap with parafilm and place in worm incubator.
4. The next day check the thaw plate for the number of live worms. Estimate the recovery
rate of each strain frozen (good, ok, excellent, etc.).
5. If thaw did not work well, regrow strain and try again. Remember to remove worms from
thawed plate after 2-3 days of recovery.
6. If the thawed cryovial is the last freezer stock of the strain, follow the worm freezing
protocol to freeze more to ensure there is always freezer stocks for each strain.

Thrashing/Mobility Assay
1. Synchronize worms in one of the following ways:
a. Bleach synchronization
b. Pick the desired number of L4-stage worms to an OP50 plate.
2. Once synchronized worms have reached adulthood, pick an individual worm into a 6-8
uL drop of M9/NGM buffer on a glass slide.
3. Allow the worms to recover from the transfer for 1 minute, and then count the number of
thrashing movements in 30 seconds under the microscope.
4. Repeat steps 2 and 3 for all worms in the trial (~15-20).

Thermotolerance
1. Synchronize worms using bleach protocol and grow worms to Day 1 of adulthood.
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2. On Day 1 of adulthood, place plates in 37C incubator or in 37C water bath (ensure plate
is properly parafilmed to prevent water leakage into plate) for 3.5 hours.
a. Note: The heat shock conditions can be optimized for each specific experiment
and worm age. The goal is to find an optimal temperature and incubating time that
yields ~50% survival rate under control conditions. That way you can visualize
both increases and decreases in thermotolerance ability in your experimental
samples.
3. Remove plates from heat shock and place in 20C incubator for 24 hours to allow for
recovery.
a. Note: Recovery time can also be optimized for each experiment. I have done 24–
48-hour recoveries.
4. After recovery period, randomly score 100 worms from around the entire plate and gently
poke with pick to determine if the worm is alive or dead.
a. Note: Ensure you are evenly scoring worms around the entire plate to ensure
random selection. I survey 100 random worms on a plate of 1000s, however you
can also only plate ~100 worms onto your plate after synchronizing and score all
worms.
5. Calculate survivability from alive/dead ratio and graph.

Lifespan Assay
1. Synchronize worms by following the beach protocol and plate L1-arrested worms on an
OP50 plate.
2. Allow worms to develop at 20C for 1-2 days, or until they reach the L4 stage.
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3. Passage ~50 L4 worms to RNAi plates.
4. Passage each worm to a new RNAi plate for the first 5 days of adulthood (gravidity
period), determining their status by observing movement and/or poking them with a
sterilized poker. Worms that do not respond to repeated poking are considered dead.
5. Dispose of deceased worms and record the number of dead, alive and censored worms.
Worms that are “bagged”, have vulva protrusions, etc are censored.
6. Repeat steps 4-5 until all worms have died.

Generating Males
1. Set up ~4 OP50 plates containing 10 L4 hermaphrodites each.
2. Heat shock 4 hours at 33C.
3. Move plates to 20C. You should get a few males in the F1 generation.
4. Maintain the male stocks by plating 9 males and 3 L4 hermaphrodites on a crossing plate
(NGM plate with agarose instead of agar, added streptomycin, and 8 ul of OP50-1
culture).

Genetic Cross Protocol
1. Plate 9 N2 males and 3 2nd strain L4 hermaphrodites onto a plate with a small dot of
OP50. Allow the worms to mate and grow progeny to L4/adulthood (~3-5 days). Half of
the progeny should be male.
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2. Pick 9 progeny males to a new OP50 plate. Add 2 3rd strain L4 hermaphrodites. Allow
the worms to mate and grow progeny to L4/adulthood (~3-5 days). Half of the progeny
should be male.
3. There is a 1/32 chance of finding a worm homozygous for both genes from the two
strains. Pick ~40 hermaphrodite progeny onto individual plates. Allow worms to selffertilize and grow progeny to L4/adulthood (~3-5 days).
4. NOTE: If all the progeny has the phenotype you’re looking for, you know the mom is
homozygous. If only ~75% have the phenotype, you know the mom is heterozygous.
5. Use assays specific for each strain of interest to determine if the progeny contain your
genes of interest.
a. For example, if one of your strains contains a roller phenotype, examine your
cross for worms with a roller phenotype. If every single worm is a roller, then you
know the mom is homozygous for that phenotype. If only 75% have the
phenotype, they are heterozygous. If that’s the case, pick progeny to individual
plates and allow to self-fertilize. If all of their progeny has the phenotype then the
mom was homozygous for both genes.
6. Utilize Punnett square genetics to determine phenotype ratios for each gene of interest.
The goal is to obtain a worm that is homozygous for both genes from each strain.

RNA Extraction
NOTES:
•

Always pipet Trizol in the fume hood and dispose in liquid/solid waste
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•

Always use filter tips

•

Spray bench, pipettors, and gloves with 70% EtOH and then RNAse away prior to
starting

•

Keep everything on ice or at 4C as much as possible

•

Discard all solid waste into biohazardous waste

1. Pick 30-35 worms into 20 ul of NGM in 1.5mL tubes and place tubes immediately on ice.
2. In the fume hood, add 250 ul of Trizol to each tube (Tri-reagent in 4C fridge).
3. Sonicate samples:
a. BioRuptor sonicator: 30 sec ON, 30 sec OFF 10x on ice.
b. Handheld sonicator: setting 2-3 twice for 12 seconds each.
4. Add 250 ul of 100% ethanol to samples and vortex for 10 seconds.
5. Load mixture into a spin column and centrifuge at max speed for 1 min at 4C.
6. Transfer spin column to new collection tube and pour flow through in 15mL tube of
hazardous waste. Discard old collection tube in hazardous waste.
7. Add 400 ul Direct-zol RNA prewash to column, centrifuge at max speed for 1 minute at
4C, discard flow through. Repeat this step one more time.
8. Add 700 ul RNA wash buffer to column, centrifuge at max speed for 1 minute at 4C, and
discard flow through.
9. Spin column for 2 minutes to dry column.
10. Place spin column into new DNAse/RNAse free 1.5mL tube.
11. Add 10-20ul RNAse-free water to column filter, let sit for 1 minute at room temperature,
centrifuge at max speed to elute RNA at 4C.
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12. Add another 10-20ul RNAse-free water to elute more RNA, let sit for 1 minute at room
temperature, centrifuge at max speed to elute RNA at 4C.
13. Nanodrop samples.
Optional in-column DNAse treatment:
1. After step 10 wash the column with 400 ul of RNA wash buffer, centrifuge for 1 min,
discard flow-through.
2. Prepare DNase 1 reaction mix as follows, recipe is given for 1 sample, make a mastermix
for as many samples as you have.
a. RNA wash buffer – 64 ul
b. Nuclease free H20 – 3 ul
c. 10x DNase 1 reaction buffer – 8 ul
d. DNAse 1 – 5 ul
3. Add 80 ul DNase 1 reaction mix directly to column filter. Incubate at RT for 15 min
centrifuge for 1 min.
4. Continue with step 11.

qPCR Protocol
1. Thaw reagents then place on ice; invert SYBR green gently to mix.
2. Make your target and control master mixes (MM) using the SYBR green general protocol
(+10% extra) or the lab’s qPCR setup excel sheet, then quickly vortex and spin down.
3. Distribute 62.7 ul of the MM to 1.5 mL tubes (as many tubes as cDNA samples to be
tested for each master mix).
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4. Make the cDNA dilutions from the excel sheet in 0.625 mL tubes.
5. Add 3.3 uL of cDNA dilutions to the 1.5 mL tubes, then quickly vortex and spin down.
6. Pipet 20 ul of completed MM+cDNA to qPCR plate wells in triplicate.
7. Seal plate with optical tape and run reaction.
8. Computer steps:
a. Turn on machine and open StepOne software once it finished starting up.
b. Click the arrow next to “New Experiment” and choose “Advanced Setup”.
c. Name the experiment.
d. Click:
i. StepOne Plus Instrument (96 wells)
ii. Quantitation – comparative Ct(ΔΔCt)
iii. SYBR green reagent
iv. Standard (~2 hrs to complete a run)
e. Click “Plate Setup” on the left and add your target and sample names on the
“Define targets and samples” tab.
f. Click to the “Assign targets and samples” tab to assign them to the correct wells.
g. Click start run.
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APPENDIX D: COPYRIGHT PERMISSIONS
Copyright permissions statement for Chapter Two:
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